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Abstract
THE EFFECT OF HYPERCHOLESTEROLEMIA ON THE
MEMBRANE LIPIDS, 3-0-

he]

METHYLGLUCOSE TRANSPORT

AND 2,3-DIPHOSPHOGLYCERATE LEVELS IN RAT ERYTHROCYTES
by Edwin J. Lester, Jr.
An increase in dietary cholesterol and cholic acid will produce
hypercholesterolemia in rats. For ten months, two groups of rats
(six in each group) were fed commercial rat pellets (control group)
or rat pellets plus cholesterol (1%) and cholic acid (0.25%) (exper
imental group). A blood sample from each animal was divided into
three aliquots for three separate experiments on the erythrocytes:
a membrane cholesterol and phospholipid determination, a 3-0-[l^cj
methylglucose (30MG) transport determination, and a 2,3-diphosphoglycerate (2,3 DPG) determination.

The 30MG transport and 2,3 DPG

aliquots were each incubated in the same five concentrations of 30MG
and glucose respectively.
The experimental group of animals exhibited a 50.3% rise in mem
brane cholesterol when compared to the control group (p < 0.01),
while the membrane phospholipid content of the experimental group
declined 36.8% when compared to the control animals (p < 0.05). The
C/PL ratio (w/w) increased from O.Idi for the control group to 1.10
for the experimental group (p < 0.01).
The 30MG transport was approximately 30% less in the experimental
animals' erythrocytes, for the physiologic incubation concentrations
of 60 and 75 mg% (p < 0.25). At the same incubation concentrations.
using glucose, the 2,3 DPG concentration dropped approximately 10% in
the experimental group as compared to the control animals (p < 0.25).
The transport of 30MG and the levels of 2,3 DPG were optimum at the
blood glucose value of 75 mg%.

There was apparently a high degree of

correlation between intracellular 30MG and 2,3 DPG concentrations;
r = 0.92 for the control animals and r = 0.77 for the experimental
group.
A significant rise in rat erythrocyte membrane cholesterol con
tent, plus a concomitant decrease in membrane phospholipids were
associated with impaired 30MG transport, Since glucose and 30MG
utilize the same membrane carrier (the band 3 protein in human
erythrocytes), the parallel decline in 2,3 DPG concentrations in
cholesterol rich erythrocytes may reflect lower intracellular glucose
and 1,3 DPG levels.
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ERYTHROCYTE MEMBRANE - STRUCTURE & FUNCTION
The human erythrocyte is a biconcave disc with the following
2
3
dimensions: LbO /jl surface area, 97 /J- volume, 7.2 /u diameter, and
2.5 /U thickness.

Its membrane is composed of 52% protein, 1|0% lipid,

and 8% carbohydrate, and consists of two major substructures — a
bilayer and an underlying shell (Sheetz, 1978).
The bilayer is a modification of the Singer-Nicolson fluid
mosaic model and contains protein, lipid, and carbohyrates.
functions, similar to many plasma membranes, include:

Its

acting as a

permeability barrier between two aqueous environments; transporting
anions, cations, sugars, and water; displaying surface receptors
(carbohydrate moieties of glycolipid & glycoproteins); and providing
various enzymatic activities, e.g., acetylcholinesterase activity
(Cooper, 1978).
The protein skeleton or shell on the bilayer’s cytoplasmic
surface functions to stabilize it; if the shell is solubilized, the
bilayer will vessiculate.

It has a profound effect in maintaining the

biconcave shape and provides the deformability the erythrocyte (7yu)
requires for passage through the fenestrations (3 - h/jl) between the
splenic cords and sinusoids.

Lastly, the shell interacts with trans

membrane proteins and determines their lateral mobility, at least
partially, on the external surface (Beck, 1977).
The bilayer lipid composition, expressed as a percentage of the
dry weight, is approximately 60% phospholipid, 15% glycolipid and
sphingolipid, and 25% neutal lipid; the neutral lipid is virtually
all unesterified cholesterol.

Phospholipids (PL) are distributed

asymmetrically in the bilayer such that the neutral PL, phosphatidyl
choline and sphingomyelin, predominate in the bilayer’s outer half;
the acidic PL, phosphatidyl ethanolamine and phosphatidyl serine,
predominate in the inner half (Grimes, 1980).

Both PL and choles

terol turn over in the membrane, while proteins are stable for the
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red cell's lifespan.

Plasma lipoproteins facilitate exchange of

cholesterol, free fatty acids, lysolecithin, and lecithin between
themselves and the erythrocyte membrane (Bruckdorfer & Graham, 1976).
A more detailed discussion of cholesterol - phospholipid interactions
and their effect on membrane function will be considered later.
Most of the red cell's carbohydrate is located on the major trans
membrane proteins (band 3 & glycophorin A), the glycolipids, and the
sphingolipids. Glycophorin A is the major sialoglycoprotein; two thirds
of its mass is carbohydrate and it includes most of the erythrocyte's
sialic acid.

It carries the blood group determinants, plus receptors

for plant lectins and the influenza virus (Marchesi et al., 1976).
Erythrocyte Proteins
Erythrocyte proteins as analyzed by SDS-PAGE (see Fig. 1) are di
vided into 8 major bands which are sometimes split; in addition, there
+ +
are at least 20 functionally important minor proteins, e.g., Na -K
++
ATPase, Ca -ATPase, acetylcholinesterase, phosphoglycerate kinase,
protein kinase, etc. The proteins are classified as either peripheral
or extrinsic (soluble in water without detergents) and integral or in
trinsic (requiring detergents for solubilization). The peripheral
proteins are: spectrin (band 1 & 2), actin (band 5)* band U, and glyceraldehyde-3-phosphate dehydrogenase (band 6). The integral proteins
are: band 3, glycophorin A = PAS I, PAS II, and band U.5 (Marchesi et
al., 1976). The following discussion will investigate the proteins
comprising the shell or skeleton, plus the bilayer proteins, with par
ticular attention directed to the bilayer protein of band 3 because of
its involvement in glucose transport.
Figure 2 provides a postulated organization for the proteins com
prising the erythrocyte shell. Spectrin exists as two coiled dimers
joined end to end to form a tetramer, and constitutes the major skele
tal protein (60-75% by weight), The actin is functionally like muscle
actin and can exist as G actin, the unpolymerized form, or F actin, the

1
2.1

}

2

2.2 -C
2.3

Spectrin

3" Ankypln

Band 3 proteins
(PAS 1) -Glycophorin

3
4.1
4.2
4.5
5

PAS 2
Actm

6

G-3-PD

7

Band 7 protein

G

Globin

+
Diagrammatic model of the human erythrocyte membrane
Fig. X
(opposite page) showing the major membrane proteins. Their
identification is commonly carried out by solubilization with
sodium dodecyl sulfate and subsequent polyacrylamide gel electro
phoresis (SDS-PAGE). The proteins are numbered according to the
sequence of the bands in the SDS-PAGE pattern after Coomassie
blue staining. This is indicated in the electropherogram above.
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Glycolipids

Glycophorin
(PAS 1)

Phospholipids
Cholesterol

6

Fig. 2 Postulated organization of the erythrocyte
cytoskeleton viewed intracellularly (Lux, 1979).

7

polymerized form.

However, the amount of actin present (approximately

k molecules per spectrin tetramer) is not consistent with long actin
filaments. Therefore it is presently believed to be organized as short
filaments. Both band ii.l and actin have binding sites on the tail of
the spectrin dimers and they comprise the crosslink between spectrin
dimers which produce the tetramers.

It is believed that band U.l

attaches to the bilayer because most of it remains when spectrin and
actin are extracted at low ionic strength.

Band it.l along with band 3

constitute known points of attachment of the shell to the bilayer
(Lux, 1979).

Together, spectrin, actin, and band l*.l form a complex

and along with band U.9 constitute the shell (Sheetz, 1979).
Ankyrin (bands 2.1, 2.2, & 2.3) is the anchor protein which links
the transmembrane protein band 3 to the spectrin network.

It is also

possible that band I4..2 is involved since it is known to be bound to
band 3.

Together, band 3, ankyrin, possibly band It. 2, and spectrin

constitute a second complex where the shell interacts with the membrane
(Fig. 2). A greater complex of the shell and the proteins linking it
to the bilayer (ankyrin, band 3, and band !|..2) has been labeled the
erythrocyte cytoskeleton (Sheetz, 1979).
There are certain aspects of this model which have not been
clarified. First, the exact stoichiometry of the spectrin-actinband h.l and spectrin-ankyrin-band 3 complexes is unknown. Secondly,
the physical state of actin and its role in cytoskeleton movement is
being investigated.

In addition, the skeletal proteins of bands

U.2, k.9, and 7 have not been given definite roles (Lux, 1979).
Functioning of the Shell
The erythrocyte shell has several major functions, including
control of membrane shape (Sheetz & Singer, 1977), membrane deformability (Mohandas et al., 1979), and the lateral distribution
(Nicholson & Painter, 1973; Shotton et al., 1978) and lateral
mobility (Schindler et al., 1979) of bilayer glycoproteins.
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Blood cold stored in ACD (citric acid, sodium citrate, & dextrose)
for 6-8 weeks or incubated at 37°C without glucose for 2h hours shows
a rapid decline in intracellular ATP and membrane lipids. Concomitant
with this is a decreased deformability (occurs in ii - 6 hours for cells
incubated without glucose) and an increased tendency for disk to
spherocyte tranformation (Weed et al., 1969). Incubation with 3mM
adenosine, at 37°C for 3 hours, will restore depleted phosphate esters,
reverse the increased rigidity, increase post-transfusion survival,
but will not reverse the lipid loss (Haradin et al., 1969; Lacelle,
1969). Therefore, it is seen that ATP is essential for maintenance of
the erythrocyte shape and deformability. From studies of the ATP de
pendent crenation of intact red cells, it has been determined that the
shell proteins are most likely to cause the shape change directly
(Sheetz et al., 1976).
Spectrin is a coiled heterodimer (one molecule of band 1 and one
molecule from band 2; total molecular weight ~h60,000 dal tons) approxo

imately 1000 A long (Goodman & Branton, 1978) which exists as a tetramer in situ (Finder et al., 1978). The tetramer, as the fundamental
unit of the shell, is cross-linked by actin as monomers (G actin) or
short filaments. The actin, however, is the /3 type in contrast to the
cX actin of striated muscle or the # actin of smooth muscle ( o< =
alpha, /3 = beta, K = gamma) (Finder et al., 1978).
Most of the erythrocyte membrane proteins are phosphorylated,
including the shell proteins; there is a spectrin kinase and a phosphospectrin phosphorylase (Fairbanks et al., 1978) as well as a kinase
and a phosphorylase for the other membrane proteins.
The ATP control of erythrocyte shape, deformability, and glyco
protein mobility is achieved through spectrin phosphorylation.

This

phosphorylation occurs multiple times (Harris et al., 1978) and the
phosphorylation sites are all clustered on polypeptide 2 (Anderson Sc
Tyler, 1978). Fairbanks et al. (1978) believe that changes in ATP
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levels would produce changes in the level of spectrin phosphorylation,
which in turn modulates the spectrin-actin cross-linking, for control
of the erythrocyte shape, deformability, and glycoprotein mobility.
As will be seen later, the regulation of this phosphorylation could
also occur through enzymatic regulation of the spectrin kinase and
phosphorylase.
The spectrin phosphorylation process and how that modulates the
spectrin-actin interaction is the major problem at present.
phosphorylation requires Mg

Spectrin

and ATP, is c-AMP independent, is stim-

ulated by increasing ionic strength (c.f. phosphorylation of band 3,
concentrations
which is inhibited), and is inhibited by high Ca
(10 ^ to 10 ^ M inhibits; 10 ^ M is physiologic) (Fairbanks et al.,
1978).

The nature of the spectrin-actin interaction after spectrin

phosphorylation is one of new intermolecular contacts without actin
polymerization,

Although actin is polymerized in vitro, it is not

polymerized in vivo,
noted earlier.

Moreover, it is a different type of actin as was

Hence, the mechanism of spectrin-actin interaction is

different from that of acto-myosin in muscle (Pinder et al., 1978).
There are a number of factors which can modulate the functioning
of the erythrocyte cytoskeleton and these include 2,3 DPG, ATP, low
density lipoproteins (LDL), and calcium.

Sheetz and Casaly (1980)

have found that physiologic concentrations of 2,3 DPG and ATP can
weaken associations within the shell, but will not dissociate the com
plex from the bilayer attachment sites.

There are ATP binding sites

on spectrin (Haley & Hoffman, 197U) and seven binding sites for 2,3
DPG on spectrin have also been measured (Shaklai et al., 1978).
Sheetz and Casaly believe the molecular explanation, consistent with
their findings, is as follows: in the shell, spectrin binds directly
to both actin and band ii.l; 2,3 DPG will dissociate the spectrin-actin
and spectrin-band U.l interactions.

In contrast, there is no dissocia

tion of spectrin-actin-band 2.1 complex or band U.l from the bilayer.
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In close agreement with the prior results, it has been found that
the lateral mobility of erythrocyte membrane proteins is increased by
the addition of 2,3 DPG and ATP.

Since the microviscosity experiments

on the bilayer lipid state showed no changes, the authors concluded
that the altered lateral mobility probably occurred through modifica
tion of interactions in the shell (Schindler et al., 1980).
When erythrocytes are oxygenated, the levels of free 2,3 DPG and
ATP increase (less of these compounds are bound to hemoglobin) and at
the same time the membranes become more ^flexible,, (Fairbanks et al.,
1978; Bunn et al., 1971).

From this result and those of the two prior

paragraphs, a new conclusion emerges,

Oxygenation of hemoglobin

alters 2,3 DPG and ATP levels; these cell metabolites regulate the
shell organizational state which in turn controls erythrocyte flexibility and glycoprotein lateral mobility,

In brief, cell metabolism

partially determines the state of the membrane.
Recent evidence also indicates that circulating lipoproteins
have a role in maintaining erythrocyte morphology,

It has been found

that addition of LDL to erythrocytes leads to echinocyte and spherocyte formation in 2 hours, followed by a U0% decrease in the phosphate
content of spectrin thereafter,

This suggests that LDL modulate the

cell shape by influencing the phosphorylation or dephosphorylation of
spectrin (Hui & Harmony, 1980).

These investigators have found that

LDL do not deplete intracellular ATP or inhibit c-AMP independent
protein kinases for spectrin phosphorylation.

Rather, LDL stimulate

membrane-bound phosphatases by a factor of two, and thereby decrease
the amount of phosphate bound to membrane proteins.

These effects

are specific for LDL since high density lipoproteins (HDL) will not
stimulate dephosphorylation or a change in cell morphology.

Rather,

HDL will protect erythrocytes against LDL-induced alterations.
Calcium, present in very low intracellular concentrations
(10”^ to 10 8 M c.f. 10~8 M in the plasma) will, if raised above the
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normal range, produce abnormal morphology and decreased flexibility.
The possible mechanism was suggested to be the association of Ca

++

with spectrin (Palek et al., 1971ajb), and as we saw earlier Ca
known to inhibit the phosphorylation of spectrin.
slightly leaky to Ca

++

and has a Ca

++

is

The erythrocyte is

-ATPase pump to asymmetrically

expel calcium without the movement of other ions. Consequently, the
++
ATP depleted cells show an increase in Ca
influx and an increased
rigidity (Grimes, 1980).

With this influx there is also a contraction

of the membrane and this occurs only with internal Ca
++

whose pH optimum is similar to that for Ca
al., 1971a).

++

concentrations
.

-ATPase activity (Palek et

Echinocyte formation has been attributed to an increased

permeability to calcium and a consequent stimulus to the pump (Weed
& Chailley, 1972).
only 30 to 5>0 Ca

LaCelle et al. (1976) have noted that there are
pumping sites per cell.

It was believed that with
++

the small number of pumping sites, local differences in Ca

concen-

tration might be reflected in the small number of spicules formed.
Interestingly, the number of spicules per echinocyte is also 30 to 5>0.
There is an additional deleterious mechanism whereby elevated intra
cellular Ca

levels not only produce, but also maintain abnormal

erythrocyte morphology.
Stabilization of the cytoskeletal network by covalent cross-links
between the cytoskeletal and integral membrane proteins results in a
decrease of membrane deformability and a fixation of erythrocytes in
their abnormal shape. Such cross-linking occurs in two circumstances:
(a) Ca++ initiated transamidative cross-links and (b) intermolecular
disulfide bonds in metabolically depleted cells (Palek & Liu, 1980).
There are inactive transglutaminases in erythrocytes which are active
.
++
at 5 x 10 ? M Ca
concentrations and catalyze the formation of
glutamyl- €-lysine bridges between membrane proteins,

The Ca

++

levels which produce this activation are found in senescent red cells,
sickle cells, or metabolically depleted cells (Lorand et al., 1978).
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Band 3 Protein
Band 3 proteins exist as stable dimers in the membrane (Nigg
& Cherry, 1979) with a prevalence of approximately 5 x lO'Vcell (Steck,
197U). It is believed that band 3 and/or glycophorin A are responsi
ble for the intramembranous particles revealed by freeze-fracture
electron microscopy of the erythrocyte membrane (Yu & Branton, 1976;
Weinstein et al., 1978).
A.

Structure
The band 3 protein has begun to be characterized structurally as

is indicated in figure 3, and consists of 3 portions:

the cytoplasmic,

the transmembrane, and the carboxyl terminal end. The carboxyl terminal
one third of the polypeptide (a 38,000 dalton segment located extra
cellularly) is not completely resolved, but little of it is believed
to be outside the cell as is indicated by the dotted lines. A segment
is indicated in the membrane due to its high concentration of hydrophobic amino acids and the extracellular segment has carbohydrate at
tached to it. The transmembrane portion (17,000 - 19,000 daltons) is
associated with anion, glucose, and bulk water transport. This portion
also traverses the bilayer at least k times in contrast to the other
major glycoprotein, glycophorin A, which only traverses the bilayer
once (Drickamer, 1980). We will look more closely at the anion and
glucose transport after a discussion of the cytoplasmic portion of band
3 and the movement of the entire protein.
The cytoplasmic portion of band 3 (Ul,000 daltons) is visible in
freeze-etch electron micrographs of ghosts as projections whose number
is compatible with the number of dimers of band 3/ghost (Steck, 1978).
A major portion of band 3 is located cytoplasm!cally (approximately ig)
and is folded like a globular protein (see Fig. 3) (Drickamer, 1980).
This aspect of band 3 is also associated with a number of other pro
teins:

(a) the proteins of the shell, (b) the other monomer of the

band 3 dimer, (c) a protein kinase, and (d) several glycolytic enzymes.
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Fig. 3 Schematic diagram of the band 3 polypeptide determined
by trypsin and chymotrypsin cleavage, plus different chemical
labeling studies (modified & adapted from Drickamer, 1980).
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B.

Associations
We have already noted the attachment to spectrin through ankyrin

and possibly band U.2.

However, the number of copies of band 3/cell

is much greater than the number of copies of ankyrin/cell.

Therefore,

only a small portion of band 3 is attached to the shell in this way —
approximately l£% (Lux, 1979).

The three sulfhydryl groups indicated

in figure 3 account for the disulfide bonds which link two copies of
the band 3 monomer for dimer formation.

The c-AMP independent protein

kinase (Lux, 1979) for phosphorylation of band 3 is located close to
the terminus (Steck, 1978).
There are three known glycolytic enzymes which are associated
with the cytoplasmic portion of band 3 in substantial amounts — phosphofructokinase (PFK) (Richards et al., 1979), aldolase (Strapazon
& Steck, 1977), and glyceraldehyde-3-P-dehydrogenase (G3PD) (Yu &
Steck, 1975).

The association is readily reversed in all cases by

increased ionic strength and metabolites which interact with the re
spective enzymes (Kliman & Steck, 1980).

This partitioning of these

sequential enzymes between the cytoplasm and the membrane may pro
vide for increased catalytic efficiency for the overall flow of glycolysis.

Also, the enzymes, once membrane bound, are not susceptible

to inhibition by negative effectors; e.g., phosphofructokinase when
membrane bound is not susceptible to ATP and 2,3 DPG inhibition
(Higashi et al., 1979).

The kinetics of association-dissociation

are rapid under nhysiologic conditions (e.g.

< 2 seconds for G3PD)

and this may be useful for rapid response to changed metabolite levels
(Kliman & Steck, 1980).

It has been calculated that there is suffi-

cient band 3 present in vivo to bind all three enzymes,

The percen-

tage of the band 3 binding sites occupied by each enzyme is 3 - 6% by
PFK, 10 - 26% by aldolase, and 7 - 2h% by G3PD.

However there should

be consideration of steric hindrance, rather than the number of available binding sites when these enzymes compete for a site.

G3PD, for

15

example, has dimensions such that it would occupy 30 - 60% of the
total inner membrane area at saturation concentrations (Higashi et
al., 1979).
C.
Movement
The band 3 protein, like many membrane proteins (most notably
rhodopsin), exhibits rotation and lateral diffusion, but little if
any movement into or out of the bilayer (Kirby & Grun, 1980).
Golan and Veatch (1980) investigated the lateral mobility of band 3
under varying conditions of ionic-strength and temperature.

They

concluded that these factors controlled interactions between the
band 3 and erythrocyte cytoskeleton. Specifically, low ionic-strength
and high temperatures affected a metastable state of the cytoskeleton
which is intermediate between tight binding and complete dissociation
from the bilayer.

Changes in this state would account for the rapid

lateral diffusion of band 3.

Although a tight complex exists between

band 3-ankyrin-spectrin, as noted earlier, the percentage of band 3
attached to the meshwork by this means is relatively small (15%).
Therefore, more likely possibilities for band 3 - shell interactions
which restrict lateral mobility would be a low affinity interaction
of band 3 with spectrin (Bennett & Stenbuck, 1979) or a nonspecific
ionic-strength and temperature dependent entanglement of band 3
with the shell.
Investivating the rotation of band 3 in the presence or absence
of specific antibodies toward a purported complex partner, glycophorin
A,, has shown that these two proteins exist as a complex in the membrane
(Nigg et al., 1980). The authors believe only a minor fraction of
the mobile band 3 is unassociated with glycophorin A. These findings
are also in agreement with the aforementioned composition of intramembranous particles visible in freeze-fracture electron microscopy.
D.

Anion Transport
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There are two major lines of evidence linking anion transport to
band 3.

First, non-membrane penetrating inhibitors, notably the

stilbene disulfonates, label band 3 selectively and produce maximum
inhibition of 1.2 x 10^ molecules per cell, This corresponds to one
inhibitor molecule per band 3 (Rothstein et al., 1976). Secondly,
partially purified preparations of band 3 confer anion transport
activity on lipid vessicles (Wolosin et al., 1977). It has been
shown that the outer, 38,000 dalton region and the transmembrane
17,000 dalton region of band 3 a^*e required for anion exchange, but
excision of the cytoplasmic, 1^0,000 dalton region has no effect on
transport (Steck, 1978). The transport process is likely to constitute a sequence of conformational changes that occur with anion binding, translocation, and release at the other surface. Since the band
3 molecule is large and traverses the membrane several times, one
might suspect that only a small fraction of the molecule undergoes
these changes. The remaining portion would function as a stable
environment within which these conformational changes occur (Passow
et al., 1980). From kinetic studies, there appear to be several
anion-transport sites on band 3 and one or more modifier sites. These
latter sites can enhance or reduce the rate of transport when another
anion or chemical modifier binds there (Rothstein et al., 1979).
The large number of copies of band 3 per cell (^ 5 x 10^) is
in accord with the rapid 1:1 exchange of HCO
and Cl when CO^ is
3
taken up by the red cell and converted to carbonic acid
H+ + HCO-,”) (Rothstein et al..
(co2 carbonic anhydrase >- h2co3
3
1976). Two additional physiologic functions of the anion transport
property of band 3 are: (a) the slow net anion movements which accompany cation movements in cell volume adjustment and (b) the slow
transport of phosphate and lactate (Steck, 1978).
E.

Glucose Transport
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The transport of monosaccharides through the erythrocyte membrane
occurs by facilitated diffusion.

Characteristics of this type of

transport include a rate greater than that of simple diffusion, spe
cific molecular features for the compound to be transported, satura
tion kinetics with an appropriate Vmax and Km, competitive inhibition
between structurally similar substrates, and inhibition by different
poisons.

From a variety of kinetic evidence some additional charac

teristics of this process are the carrier's (transport protein) greater
access to and affinity for sugars at the extracellular membrane sur
face by comparison with the intracellular surface (LeFevre, 1975).
Barnett et al. (1975) has advanced a model whereby the glucose binds
to the outside of the transport protein; the protein undergoes re
arrangement to a second conformation which transports it and exposes
it to the intracellular environment.

As noted earlier, this is the

transport mechanism envisioned for band 3 anion transport.
The site of erythrocyte glucose transport has been investigated
by use of various specific protein cross-linking chemicals, plus the
agent cytochalasin B which is a known competitive inhibitor of glucose
transport in a variety of tissues.

Lin and Spudich (197^) have es

tablished a number of significant points regarding glucose transport
d
by utilizing cytochalasin B. They determined there were 3 x 10 high
affinity binding sites for cytochalasin B per cell.

This corresponds

very closely to the number of transport related D-glucose binding
sites per cell (2-5 x 10^) found by Kahlenberg (1976). Moreover, it
has also been shown that there are approximately 5 x 10
per cell (Steck, 197U).

band 3 dimers

Lin and Spudich (197U) also found that D-

glucose competitively inhibited the cytochalasin B binding and the in
hibitory capacity of other sugars depended on their affinity for the
transport system.

They concluded that 80% of the high affinity cyto-

chalasin B binding sites were intimately related to glucose transport.
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Proof that cytochalasin B and D-glucose are likely to be inter
acting with the same transport protein has come from a comparison of
the stereochemistry of D-glucose and cytochalasin B (Taylor & Gagnea,
1975).

The spatial distribution of h oxygen atoms in cytochalasin B

is almost identical with the distribution of the h oxygen atoms in
/B -D-glucopyranose.

These latter oxygens have been implicated in

hydrogen bonding to the carrier protein associated with D-glucose
transport.
Kahlenberg (1976) has selectively eluted spectrin and bands 2.1,
2.2, 2.3, U.l, 5, and 6 from erythrocyte ghosts to find that there
has been no effect on D-glucose uptake,

All the sugar transport prop-

erties are associated with bands 3, U.5, and 7.

By specific cross-

linking of band 3 through the oxidation of sulfhydryl groups, he
observed a 70% inhibition of D-glucose uptake and an altered mobility
of band 3 on SDS-PAGE.

The uptake of glucose returned and the origi

nal mobility was restored when cross-linking was reversed by reduction.
Furthermore, the incorporation of this partially purified protein into
liposomes resulted in a preferential uptake of D-glucose (Zala &
Kahlenberg, 1976).
From the foregoing, it is established that the localization of
D-glucose transport in human erythrocytes is band 3.

However, bands

U.U and 7 were present in the preparations of Kahlenberg and a 30%
residual glucose binding remained.

Recent evidence by a number of

investigators has shown that band U.5 is also involved in D-glucose
transport.

This protein also is inhibited by cytochalasin B, trans

ports glucose when reconstituted into bilayer vessicles, and is
found at approximately 0.6 x 10^ sites per red cell (Goldin & Rhoden,
1978).
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CHOLESTEROL AND THE ERYTHROCYTE MEMBRANE
The laboratory rat, although useful for the study of human
cholesterol metabolism, is dissimilar in a number of areas.

These

include the serum cholesterol levels, the site of cholesterol syn
thesis, the response of organ cholesterologenesis to dietary cho
lesterol, the distribution of cholesterol among the classes of
lipoproteins, and the fatty acid composition of cholesterol esters.
For humans, total serum cholesterol values range from 11^ - 3U0 mg/
100 ml with an average of 250 mg/100 ml. By comparison, SpragueDawley rats have total serum cholesterol values of h3 - 105 mg/100
ml with an average of approximately 70 mg/100 ml. The major site of
cholesterol synthesis in man is the liver, while in the rat it is
the intestinal mucosal cells (Chevallier, 1977a).
Three factors determine plasma cholesterol levels — dietary
absorption, synthesis, and fecal excretion (Chevallier, 1977b).
Dietary cholesterol absorbed into the intestinal mucosal cells re
quires bile salts (these function as a detergent and activate cho
lesterol esterase) and pancreatic secretions (rich in bicarbonate
to produce neutralization of the intestinal contents). The intesti
nal synthesized cholesterol and the absorbed dietary cholesterol are
esterified before incorporation into chylomicrons for transport
through the lymphatic system (thoracic duct) to the blood. There is
evidence that the degree of esterification of cholesterol in lymph
may be related to the dietary cholesterol load because the rat’s
cholesterol esterifying system increases in activity with high cho
lesterol diets (Murthy et al., 1961). Although we are discussing
chylomicrons from the standpoint of dietary cholesterol, their major
constituent (86%) is dietary triglyceride.

The chylomicron clear

ance and transport to the liver is as follows: (a) they receive apo
protein C-II from HDL for activation of lipoprotein lipase (LPL)j
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(b) the triglycerides (TG) are hydrolyzed by activated LPL
(located on endothelial cells of extrahepatic capillaries) to pro
duce free fatty acids (FFA) and diglycerides (DG); (c) the FFA and
DG are metabolized in adipose and other extrahepatic tissues; (d) the
removal of TG produces a remnant chylomicron half the diameter of the
original one and enriched in cholesterol esters; and (e) this remnant
chylomicron is taken up by the liver, where the cholesterol ester is
hydrolyzed, trans-esterified, and incorporated into the storage pool
of cholesterol esters (Boyd, 1975)•
When cholesterol is fed to rats the liver cholesterologenesis
decreases, the hepatic cholesterol ester pool increases, and the cir
culatory concentration of cholesterol increases (Fears & Umpleby,
1979). This hepatic cholesterologenesis response to dietary cholesterol also occurs in man, but is quantitatively less, The effect of
cholesterol feeding has little effect on cholesterol synthesis in the
intestine in either man or the rat (Boyd, 1975).
From the standpoint of the liver*s free cholesterol pool, there
are several inputs: dietary and intestinal cholesterol esters in the
chylomicrons, hepatic synthesized cholesterol, hepatic cholesterol
ester stores, and a minor amount from other body sites.

The output

from this pool is bile (free cholesterol and bile salts) and the
plasma very low density lipoproteins (VLDL). Turley and Dietschy
(1979) have found that the output of biliary cholesterol in the rat
is independent of hepatic cholesterol synthesis, the size of the
hepatic cholesterol ester pool, and the uptake of chylomicron choles
terol.

As mentioned above, dietary cholesterol inhibits hepatic syn

thesis and has no effect on intestinal synthesis.
cholesterol via bile is constant.

The output of liver

Therefore, cholesterol fed rats

will have increased chylomicron cholesterol which will be reflected in
an increased concentration of free cholesterol carried by the liversynthesized VLDL.
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Serum Cholesterol
A.

Cholesterol Distribution between Lipoprotein Classes
The distribution of serum cholesterol between the three major

lipoprotein classes — HDL, LDL, and VLDL — is different for humans
and the rat. Serum cholesterol, whether free or esterified, is dis
tributed among human lipoprotein classes as follows: HDL - 20 to 1*5%;
LDL - 50 to 70%; and VLDL - 5 to 10% (Grimes, 1980). For the SpragueDawley rat the distribution consists of: HDL - 59 to 6i*%; LDL - 26 to
37%; and VLDL - 1* to 10% (Feldman et al., 1978; Gidez et al., 1965).
We notice from these figures, that for humans, LDL carry the bulk of
the cholesterol and 75% of the LDL mass is lipid, of which 60% is
cholesterol (50% esterified and 10% unesterified) (Bhagavan, 1978).
In the rat, the HDL carry the bulk of the cholesterol.
As we have noted, an increase in dietary cholestetol will yield
increased serum cholesterol values.

Also, for rats, the addition of

cholic acid plus cholesterol will elevate serum cholesterol to higher
values (219 mg/100 ml) than with either cholesterol (80 mg/100 ml) or
cholic acid (90 mg/100 ml) alone (Tsai & Dyer, 1973).
Elevating the dietary cholesterol intake for rats will also
shift the cholesterol distribution among the lipoprotein classes.
Specifically, there will be an increased concentration of cholesterol
carried by LDL (36.5% increase) and VLDL (28.7% increase), but a de
crease in that carried by HDL (10% decrease) when compared to the
control animals (Fears & Umpleby, 1979).

These authors in addition

to noting an increase in circulating cholesterol (distributed as de
scribed above), also found in the liver and extrahepatic tissues a
decrease in cholesterologenesis, with concomitant increases in es
terified cholesterol concentrations.

They noted no change in the

total extrahepatic cholesterol content of the tissues, and attributed
this to an LDL receptor mediated uptake system similar to that
described by Brown and Goldstein (1976).

Fear and Umpleby’s in vivo
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results support the control of intracellular free cholesterol levels
with increased dietary cholesterol, through a decrease in [3 -hydroxy/3 —methylglutaryl—CoA reductase (HMGCoA reductase) activity, a de
crease in LDL receptor systhesis, and an increase in acyl CoA :
cholesterol acyltransferase (ACAT) activity.

They also found with

the high cholesterol diet the appearance of HDL^, a plasma lipoprotein
obtained from cholesterol-fed swine.

This lipoprotein will also

bind LDL receptors without the obligatory apoprotein B (apo B).
HDL^^’s high apoprotein E content, which presumably has peptide regions
homologous to apo B, makes this binding possible (Mahley & Holcombe,
1977).
B.

Lecithin : Cholesterol Acyltransferase (LCAT)
Of the cholesterol in the plasma, 70% is esterified and 30% is

free cholesterol, with the LCAT enzyme responsible for forming most
of the esterified cholesterol.
reaction:

The LCAT catalyzes the following

Lecithin + Cholesterol

->-Cholesteryl ester + Lysolecithin.

It transfers a fatty acid, usually unsaturated, from position 2 of
lecithin to the cholesterol for esterification.

The enzyme is normal

ly bound to HDL (which contains its activator, apoprotein A-I) and
is responsible for the increase in cholesteryl esters in LDL as it is
produced in the plasma from the nascent, liver-synthesized VLDL.
During this process, there is a reversible exchange of cholesterol
between HDL and LDL.

As noted above, the unsaturated fatty acid in

position 2 is transferred and it is usually linoleic; therefore,
esterified cholesterol in HDL and LDL contains linoleic acid,

This

is in contrast to the ACAT-formed cholesteryl esters in the cell
which contain oleate and palmitoleate.

The LCAT activity is also

inactivated by heat and bile salts (Bhagavan, 1978).
C.

The Role of Dietary Fat with respect to Serum Cholesterol

1.

Alteration of Cholesterol Levels
In the intestine, triglycerides are hydrolyzed to monoglycerides.
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diglycerides, and free fatty acids; the cholesterol esters are
hydrolyzed by bile salt-activated cholesterol esterase to produce
cholesterol and free fatty acids.

The cholesterol is initially

present in an emulsion, and later in a water soluble micellar phase
from which the absorption takes place.

Three limiting factors for

the rate of cholesterol absorption are the conversion from emulsion
to micelle, the concentration of cholesterol in the micelle, and the
type of triglyceride present with the cholesterol (Boyd, 1975).

The

level of serum cholesterol is not dependent upon the amount of
dietary fat, but rather the composition of the fat (McGandy & Hegsted,
1975).

Keys et al. (1957) determined the effect of different fatty

acids on serum cholesterol values and found the following:
(a) saturated fatty acids with carbon chains > 10, elevated the levels;
(b) monounsaturated fatty acids are neutral, i.e. addition or sub
traction of these from the diet has no effect upon serum cholesterol
levels; and (c) increasing polyunsaturated fatty acids (PUFA) decreases serum cholesterol levels,

The mechanism for PUFA lowering

of serum cholesterol values is not clear, but a number of possibilities exist.

First, increased excretion could be achieved through

stimulated intestinal excretion of cholesterol, stimulated choles
terol oxidation to bile acids, and increased liver metabolization
of PUFA cholesterol esters as compared to those with saturated fatty
acids.

Secondly, there may be a shift in the distribution between

plasma lipoproteins and the tissues,

It has been found that sat-

urated free fatty acids cause VLDL secretion by the liver to proceed
at a higher rate, and to produce smaller particles with relatively
more cholesterol; these smaller particles are utilized at the extrahepatic tissues at a slower rate than are the larger particles,

All

these would tend to elevate serum cholesterol (Harper et al., 1977).
2.

Alteration of Cholesterol Distribution between Lipoproteins
Feldman et al. (1979) fed rats three different types of
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homogenous 18-carbon chain triglycerides and looked at the cholesterol
balance.

These triglycerides were tristearin (saturated fatty acid),

triolein (monosaturated fatty acid), and safflower oil (PUFA).

In

comparison to the cholesterol distribution between lipoproteins in
the control group, the tristearin group had a 25% increase in HDL
cholesterol and an 80% decrease in LDL cholesterol, The triolein fed
animals showed changes in the same direction — U0% increase for HDL
and 60% decrease for LDL. By comparison, there was no change in the
safflower fed animals' HDL and LDL cholesterol.
3.

Fatty Acid Composition of Cholesteryl Esters
The fatty acid composition of cholesterol esters among the lipo

protein classes in humans is fairly similar, with linoleic being
predominant, For the rat, it varies among lipoprotein classes and
shifts with changes in diet.

The rat's fatty acid composition of
cholesterol esters in the liver and VLDL is primarily oleic (38%) and

linoleic (25%), in the HDL is linoleic (35%) and arachidonic (li6%),
and in the LDL is a mixture intermediate between that for the other
two classes. When olive oil (monounsaturated fatty acid) and choles
terol are added to the diet, the cholesteryl ester fatty acid compo
sition changes so that VLDL and LDL have similar percentages for the
content of oleic and linoleic acid in each — 83% and 7% respectively.
The liver, however, has 75% oleic and 20% linoleic acid in its cholesteryl esters. The HDL fatty acids esterified to cholesterol, in
comparison to the control group mentioned above, have an increased
oleic content, from 5% to 2U%, no change in the linoleic content, and
a decreased arachidonic acid content, from U6% to 23%. A fat free
diet with cholesterol produces the clinical signs of essential fatty
acid deficiency.

The liver and VLDL again have a similar fatty acid
composition in their cholesterol esters, with 60% oleic acid, 18%

palmitoleic acid, and no linoleic acid. The HDL fatty acid composition in the cholesterol esters has changed dramatically, with
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oleic increasing from 5% in the controls to 30%, linoleic declining
from 3U% to h%y arachidonic declining from U6% to approximately 13%,
and significant amounts of eicosatrienote (~13%) appearing (Gidez
et al., 1965). The authors note that apparently there is preferential incorporation of polyenoic acids into HDL with the essential
fatty acid deficiency, and possibly different mechanisms exist for
cholestetol ester formation in different lipoproteins. Egwin and
Kummerow (1972) concluded that the accumulation of long chain unsat
urated fatty acids (chain length C^q and greater) into plasma
lipoproteins results from linoleate deficiency.
It is known that the turnover rate of cholesterol esters be
tween lipoprotein classes is different in the rat (as in humans), but
is also different within lipoprotein classes. This variability in
turnover within a lipoprotein class is due to the fatty acid moiety
Specifically, cholesterol esters experience a higher
of the ester.
turnover rate in LDL and VLDL than in HDL. Within the LDL and VLDL
classes the turnover, classified by the degree of fatty acid unsat
uration, is as follows: monoenes>saturated = dienes> tetraenes. For
the HDL class, the results are almost the reverse: tetraenes> dienes>
monoenes = saturated. Therefore, cholesterol ester turnover in the
rat, as opposed to man, is determined by the particular lipoprotein
class and the fatty acid moiety of the ester (Gidez et al., 196?).
The high percentage of polyenoic acids in HDL may be accounted

for by the LCAT enzyme located there which transfers PUFA.

This

lipoprotein class has a lower turnover rate of cholesterol esters,
while, by comparison, VLDL and LDL have higher turnover rates and
possibly a different mechanism for esterification (Gidez et al., 1965).
Cholesterol and Phospholipid Exchange between Lipoproteins and the
Erythrocyte Membrane
The bodyfs cholesterol is generally divided into three pools
with respect to the availability for exchange. The cholesterol of
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the nervous system is virtually unexchangeable with the plasma even
over a period of 6 - 12 months.

A slow exchange pool (10 - 1*0 days)

includes the muscles, skin, and kidneys.

The rapid exchange choles

terol pool consists of the plasma, erythrocytes, liver, and bile
(Boyd, 1975). Within the rapid exchange pool phospholipids and unesterified cholesterol exchange among the lipoprotein classes; HDL
and LDL free cholesterol exchange with the erythrocyte membrane.
Since the red cell has no de novo synthesis of phospholipids and cho
lesterol, the plasma lipoprotein composition of phospholipid and
and cholesterol determines the erythrocyte membrane composition of
these molecules.
Cholesterol Exchange
A.
Both HDL and LDL exchange free cholesterol with the erythrocyte
membrane, but cholesterol esters are not exchanged (Bruckdorfer &
Graham, 1976). It is important to recall that almost all the membrane
cholesterol is unesterified.
We noted earlier that LCAT converts cholesterol in the nascent
VLDL, arising from the liver, to cholesterol esters in the LDL during
the VLDL to LDL transformation process, The HDL which is synthesized
in the liver also has a high cholesteryl ester content, Hamilton et
al. (1976) proposed that the nascent HDL consists of phospholipids
and free cholesterol. It binds LCAT and its activator apo A-I, and
converts the surface phospholipid and free cholesterol to lysolecithin
and cholesteryl ester, The non-polar cholesteryl esters move into
the core of the HDL and lysolecithin is transferred to albumin.
Glomset (1970) has proposed the scheme for exchange of choles
terol between HDL and the erythrocyte membrane shown on the next page.
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The LCAT esterifies surface cholesterol in the HDL which moves to the
hydrophobic core as described above,

The HDL then collides with the

erythrocyte membrane to bind hydrophobically (Bruckdorfer & Green,
1967) during which time the HDL receives free cholesterol from the
erythrocyte.

This fusion seems to occur only at sites in the erythro-

cyte membrane where cholesterol is situated, since cholesterol depleted red cells will not take up
teins.

- cholesterol from [3 lipopro-

Moreover, the remaining cholesterol can be removed by in

cubation with cholesterol depleted LDL (Bashford et al., 196U).
Finally, the HDL releases its cholesteryl esters to the liver.

There

fore, in addition to regulating plasma levels of free cholesterol,
lecithin, and cholesterol esters, LCAT also maintains the cholesterol
content of the erythrocyte membrane.
Proof of this scheme has come from patients with congenital LCAT
deficiency whose red cell membranes have increased amounts of cholesterol and lecithin.

The lipoproteins also had abnormally high amounts

of free cholesterol and lecithin, but low levels of cholesterol esters.
In addition, there was an abnormal lipoprotein pattern with a lipopro
tein called LP-X (which contained mostly unesterified cholesterol), a
little LDL, a VLDL with [3

electrophoretic mobility, and two types of

abnormal HDL particles (Bhagavan, 1978).

Additional evidence is

found when pathologic, cholesterol laden erythrocytes lose their
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cholesterol upon incubation with normal serum (Grimes, 1980).
All the erythrocyte cholesterol is available for exchange (Lange
& D’Alessandro, 1978).

Cooper (1978) states that exchange involves

the entire free cholesterol pools of both the plasma lipoproteins and
the erythrocyte membrane.

In contrast, Bruckdorfer and Graham (1976)

indicate all the LDL unesterified cholesterol is available, but only
62% of the HDL cholesterol.
There are a number of factors which do not affect the exchange
process.

It is pH independent near physiologic values, and the ionic

strength of the medium has no effect on the net flux rate between
both HDL and LDL and the erythrocytes.

At high salt concentrations

a greater fraction of the red cell cholesterol exchanged with HDL as
opposed to the LDL (Bruckdorfer & Graham, 1976).

Modification of

surface proteins on erythrocyte ghosts or LDL did not affect the rate
Also, the exchange is independent of ATP
3
(Bruckdorfer & Green, 1967). The speed of exchange of H-cholesterol

of cholesterol exchange.

between plasma lipoproteins and erythrocytes is the same in young
(2 months) and old (li| months) rats for both in vitro and in vivo
measurements (Hruza Sc Zbuzkova, 1975).

In contrast, the exchange

flux is temperature dependent, but this is not related to plasma LCAT
activity (d*Hollander Sc Chevallier, 1972).
In considering the kinetics of the cholesterol exchange between
HDL, LDL, and erythrocytes, the rate of flux seems to follow this
sequence:

HDL

LDL > HDL

Sc Hilderman, 1970).

membrane > LDL-*—membrane (Quarfordt

This suggests that cholesterol exchange is easier

between lipoprotein classes than with the membrane, and is preferential between HDL and the membrane.

However, it is generally conclu

ded that a bicompartmental model, with HDL/LDL as one compartment
and the membrane as the other, reflects the reality of the situation
in the blood (dfHollander Sc Chevallier, 1972).
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The cholesterol content of erythrocyte membranes is dependent
upon the cholesterol : phospholipid (C/PL) molar ratio of their
milieu, whether it be lipoproteins or cholesterol-lecithin liposomes.
If the liposome C/PL molar ratio > 1.0, then erythrocytes or lipo
proteins incubated with them will become cholesterol enriched,

If

the liposome C/PL molar ratio < 1.0, then the erythrocytes or lipo
proteins will be depleted of cholesterol (Cooper et al., 1975)•

For

humans, the C/PL molar ratio is 1.0, for rats it is 0.?6 (Bruckdorfer
& Graham, 1976).

This dependence of cholesterol exchange on the

amount present in the two pools (the membrane and the lipoproteins)
is best appreciated by recognizing that cholesterol is virtually
water insoluble.

The amphipathic phospholipid molecules in both

pools solubilize the cholesterol.

Therefore, the partitioning of

cholesterol between the membranes and lipoproteins is determined by
the amount of phospholipid relative to the amount of cholesterol in
each pool, i.e., the C/PL ratio (Cooper, 1978).

Cholesterol will

exchange from a bilayer with a high C/PL molar ratio to one with a
lower C/PL molar ratio.
B.

Cholesterol Distribution within the Bilayer
The distribution of cholesterol between the two halves of the

bilayer is still not clear.

Fisher (1976), utilizing freeze-fracture

techniques and quantitative thin-layer chromatography, found an
asymmetric distribution with a ratio of 2:1, exterior:interior.
Support for this asymmetric distribution comes from Poznansky and
Lange (1978) who believe it to be 70:30, exterior:interior,

In

contrast, Blau and Bittman (1978), using an antibiotic which reacts
with cholesterol, determined a symmetrical distribution between the
inner and outer halves of the bilayer.
What is certain, however, is that cholesterol in the outer half
and inner half exchange with each other, i.e. ,,flip-flopn (Lange et
al., 1977; Kirby & Green, 1977).

For human erythrocytes this occurs
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with a half-time of less than £0 minutes (Lange et al., 1977), while
for rats it is quite similar with a t! < 1 hour (Kirby & Green, 1977).
It appears that only the cholesterol in the outer half of the bilayer
is available for exchange under equilibrium conditions, i.e., no net
movement of cholesterol into or out of the membrane occurs, but
there is a very slow "flip-flop11 to the inner half,

Once cholesterol

has been removed from the outer half, a non-equilibrium situation
exists and exchange of cholesterol from the inner half to the outer
half can occur (Poznansky & Lange, 1978).
C.

Phospholipid Composition and Exchange
The distribution of phospholipids (PL) in rat erythrocytes is

similar to that in human erythrocytes.

The outer half of the bilayer

is predominantly phosphatidyl choline (PC) and sphingomyelin (SM),
while the inner half is mostly phosphatidyl ethanolamine (PE) and
phosphatidyl serine (PS).

Rat erythrocytes contain more PC and less

SM than do human erythrocytes; however, the differences balance such
that the amount of choline containing phospholipids in the outer half
of the bilayer is the same in both types of erythrocytes (h2% of the
total phospholipid) (Renooij et al., 1976).
When the different phospholipids are considered, their ease of
exchange with erythrocytes follows this sequence: lyso PC > PC > SM.
The predominance of lyso PC exchange may well be due to the plasma
LCAT which continuously generates lyso PC.

There is also some degree

of specificity for PL exchange among the classes of lipoproteins.
The majority of lyso PC exchanged with lipoproteins whose density >
1.21, i.e. the very HDL; it exchanged to a lesser extent with HDL.
The exchange of PC and SM occurred equally with HDL and LDL
(Bruckdorfer & Graham, 1976).
The major pathway for renewal of erythrocyte PL is by exchange
with the serum lipoproteins and this exchange occurs at the outer
surface of the membrane (Renooij & Van Golde, 1976).

Although the
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majority of the PC in rat and human erythrocytes exists in the outer
half of the bilayer, PC does exist in both halves of the membrane and
is available for exchange from the inner half by a slow "flip-flop"
to the outer half. Specifically, for rats the outer membrane half
(CM) contains 50 - 60% of the total PC and exchanges with o.
- 2
hours.

The inner membrane half (IM) contains I4.O - 50% of the total

PC and exchanges with a slower rate whose half-time for equilibration
= 7 hours (Van Meer et al., 1980). The authors also utilized a
PC-specific exchange protein which was synthesized in the liver and
presumably facilitates exchange. However, they required a much higher
concentration of this exchange protein for erythrocyte-micro some PC
exchange, than with PL vessicle-liver microsome exchange of PC.
The turnover of erythrocyte phospholipid fatty acids in situ
has been shown to proceed by exchange of the intact phospholipid
molecule and/or deacylation of endogenous membrane PL followed by
reacylation of the lysophospholipid (Dise et al., 1980). The rat
erythrocyte CM contains no disaturated PC, while the IM contains
quite a lot of disaturated PC. It has been shown that the rate of
renewal of unsaturated PC is more pronounced in the outer layer of the
membrane, as might be expected. It is known that unsaturated PC
which predominates in plasma lipoproteins (they contain no disaturated
PC) exchanges with the OM. The erythrocyte directs its deacylation/
reacylation activity towards the formation of disaturated PC at the
IM.

Flip-flop mechanisms, from the previously mentioned study, would

determine the PC distribution between the OM and Hi (Renooij & Van
Golde, 1979).
Dietary fat certainly has an effect on PL fatty acid composition.
but differs depending upon the fatty acid and the PL containing the
fatty acid. It has been shown that the arachidonic acid content of
the total rat erythrocyte PL is independent of dietary fat, as are
stearic and palmitic acid to some extent. In contrast, a safflower
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oil diet (high in linoleic acid) results in increased linoleic acid
in the PL.

Analogously, a lard diet increases the oleic acid

content of the PL (Momsen et al • i 1962).
and linoleic acid

The changes in PL oleic

content with dietary manipulation are more evident

in the choline-containing phospholipids — PC and SM — than in the
noncholine-containing phospholipids.

The arachidonic acid content

of PL is unchanged even on a lard diet, which contains some linoleic
but no arachidonic acid.

Apparently, arachidonic acid is sufficiently

important for erythrocytes that it is synthesized from the linoleic
acid (Walker & Kummerow, 1963).
The fatty acid composition of erythrocyte PL also affects the
cholesterol exchange rate between lipoproteins and the membrane. It
has been shown that both the chain length and the degree of unsatura
tion are important (Green, 1977). Exchange is more rapid when the
degree of unsaturation is greater (Spritz, 1965), and more rapid with
shorter chains. This improved exchange with more unsaturation and
shorter chain length is probably due to the PL-cholesterol structural
interactions involved in optimal packing of these molecules. This
interaction will be discussed shortly.
Although we have discussed the exchange of cholesterol and phos
pholipids between the erythrocyte membrane and lipoproteins indepen
dently, they occur simultaneously. A pathologic condition which ex
hibits the possible interaction of these exchange processes is
obstructive liver disease.

Patients with this condition have target

cells which have accumulated excesses of both cholesterol and phos
pholipid; the phospholipid increase is confined to lecithin. Two
processes determine these increases. First, there is the isolated
transfer of cholesterol from lipoproteins to red cells determined by
the C/PL molar ratio of the lipoprotein and that of the membrane.
This is probably a minor contributor since the C/PL molar ratio of
LDL does not increase substantially in liver disease.

The larger
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anount of cholesterol and lecithin accumulated seems to be due to an
independent transfer of phospholipid from the LDL based upon the
LDL's PL/protein ratio, which is higher in liver disease,

Once the
erythrocyte has added the PL, its C/PL ratio decreases,
Now there
is a difference in the LDL and membrane C/PL ratios and cholesterol
moves from the LDL to re-establish equilibrium,

In summary, the

total red cell membrane cholesterol content is determined by: (a) the
membrane PL content, which is influenced by the LDL’s PL/protein
ratio; (b) the fraction of PL in the membrane which is available to
solubilize cholesterol (PL in the form of boundary lipids around
membrane proteins would be unavailable); and (c) the LDL's C/PL ratio
which is in equilibrium with the membrane (Cooper, 1978).
Structural Considerations of Cholesterol, Phospholipids, and Proteins
in Membranes and Model Membrane Systems
A.

Membrane and Phospholipid Bilayer Dynamics

Phospholipid monolayers, bilayers, and liposomes have been
utilized as model systems to investigate PL dynamics, the effect of
cholesterol on those dynamics, and cholesterol-PL-membrane protein
interactions.
Phospholipid motion can be divided into two motional modes:
intramolecular motion and motion of the entire molecule, The intra
molecular motion consists of rotation about single bonds, swinging
of the fatty acyl chains (fluidity), and polar head group conformational changes. Phospholipid molecules as a whole can rotate, under
go lateral translation in the plane of the membrane, or flip-flop
from one half of the bilayer to the other,

These motional modes
manifest themselves in the bilayer system properties of thermotropic
phase transition, bilayer fluidity, and various interactions:
PL - PL, PL - cholesterol, PL - protein, and cholesterol - protein
(Huang & Thompson, 1978).
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The bilayer phospholipids can exist in one of two states — gel
or liquid-crystalline.

In the gel state the PL fatty acid chains are

fairly rigid, extended, and regularly packed; in the liquid-crystal
line state they are more fluid and mobile.

The gel—►liquid-

crystalline phase transition (g----i-lc) occurs over a very narrow
temperature range (approximately a degree) whose center is designated
the transition temperature (T^). The short temperature span indicates
that it is a cooperative phenomena. The gel state (below T^) is
characterized by fatty acid chains which have a trans organization
such that they are relatively rigid.
an ordered packed state.

Minimum chain motion creates

The liquid-crystalline state (above T^.)

occurs when increasing temperature produces increasing fatty chain
motion. Carbon - carbon bonds in the fatty acid chains undergo a
trans—► gauche conformational change along the length of the chain,
i.e., a "melting” of the chain. However, the motion along the chain
is not uniform, with motion from the glycerol backbone to carbon-9
reduced. By contrast, the terminal one-half of the chain increases
its motion (Green, 1977).
Factors which affect the transition temperature include the
degree of lipid hydration, the fatty acid chain length, the degree
of unsaturation, chain branching, and the type of polar head group.
If the T^ is decreased it implies the transition would require less
energy input for the g—^-Ic transition. A decreased T^ can be
obtained by increasing the lipid hydration, decreasing the chain
length, increasing the degree of unsaturation, and increasing chain
branching. The T^ for most lipid mixtures in biological membranes
is well below the ambient temperature of the cells. Therefore,
under physiological conditions the PL are in the liquid-crystalline
state.

These same aforementioned factors which decrease the T^ in

model membrane systems also increase the fluidity of biological
membranes.

Saturated fatty acids form straight chains, strong
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interchain interactions, and a rigid membrane.

Unsaturated fatty

acids have bends which interfere with optimal chain packing.

The

double bond also enhances rotation about the C-C single bonds im
mediately adjacent on each side.

Both these factors increase chain

motion, but only in the terminal one-half of the chain (Huang &
Thompson, 1978).
During the gel to liquid-crystalline phase transition certain
whole molecule motions occur.

In the liquid-crystalline state wobble

along the long axis of the PL increases; the axial rotation occurs
•1c phase transition. Lateral translation also
well below the g
occurs in the liquid-crystalline state (it is undetectable in the gel
state) presumably by interchange of neighboring pairs of PL. This
n

exchange rate is 10 /sec. to yield an in plane velocity of l/^m/sec.
(Huang & Thompson, 1978)
The Effect of Cholesterol on Membrane and Bilayer Dynamics
B.
Cholesterol tends to broaden the transition temperature range
1c phase changes, i.e., it interferes with the cooperative
for g
effect for the "melting” of the fatty acyl chains. At temperatures
> T

"L

all the PL should be in the liquid-crystalline state and fluid

in their motion. Cholesterol keeps some of the molecules in the gel
state to rigidify the membrane. For temperatures < T^ most molecules
are in the gel state, but some remain in the liquid-crystalline state
due to the cholesterol, and hence cholesterol increases the fluidity
of the bilayer. Therefore, cholesterol has the ability to eliminate
the sharp phase transition and associated change in bilayer fluidity.
It produces an "intermediate fluidity" over a broad temperature
range (Green, 1977).
Cholesterol affects the gel state of bilayers by taking the ter
minal portion of the fatty acid chain, which is normally at 30° to the
plane of the bilayer, and orienting it perpendicularly.

This sterol

also increases the the amount of bound water and fatty acid chain
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motion by the trans

•^gauche conformational changes (Green, 1977).
The effect of cholesterol upon the liquid-crystalline state, i.e.

the physiologic situation in biological membranes, is different for
various portions of the fatty acid chain.

It decreases the mobility

of the 10 carbons near the glycerol (less gauche conformations) and
increases the chain mobility beyond C-10 (more gauche conformations)
to produce fatty acyl chains which are rigid near the bilayer surface,
but fluid in the hydrophobic core. There seems to be little direct
effect of cholesterol on the terminal methyl and little disruption of
the polar head group in affecting chain motion (Huang, 1977).

There

is electron microscopic proof of cholesterol*s role in changing PL
motion. In bilayer freeze-fracture micrographs, the gel state appears
banded and the fluid state smooth. Addition of 25 mole % cholesterol
converts a banded pattern to a smooth one (Green, 1977).
Cholesterol has a well known condensing effect upon monolayers
or bilayers of mixed fatty acid PL in the liquid-crystalline state.
There is no such effect for saturated fatty acid PL in the gel state.
The condensing effect is defined as the reduction in the mean area/
molecule of a PL monolayer upon the addition of a sterol. In other
words, the average area/molecule for the PL-sterol mixture is < the
average area/molecule for the PL monolayer or bilayer alone (Green,
1977).

This is illustrated schematically below.

In summary, the interaction of cholesterol with phospholipid
bilayers has a number of effects: (a) the condensation effect,
(b) the decrease of fatty acyl chain mobility near the glycerol
backbone, (c) the increased chain mobility in the terminal half, (d)
the suppression of the thermotropic phase transition, and (e) the
decrease in the lateral diffusion rate of egg (mixed saturated and
unsaturated fatty acid chains) phosphatidyl choline. Interestingly,
one notes that phosphatidyl choline and sphingomyelin, the two major
phospholipids in the outer half of the erythrocyte membrane, each
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have the same affinity for cholesterol.
both above and below the

This holds for temperatures

(Lange et al., 1979).

Therefore, some
of these conclusions for model systems may be extended to in vivo
situations.

sterol
(cholesterol)
\ added /
Liquid-expanded PL monolayer
(liquid-crystalline state)

Condensed PL monolayer
(gel state)

fatty acid molecules are flexed &
rotating; cavities exist between
the chains

fatty acid molecules are
extended and alligned;
no cavities between the
chains

Y
condensation
effect

a) no condensation effect
b) disruption of fatty
acid chains

Lipids can affect membrane fluidity in several ways. First, the
PL composition affects fluidity, e.g • j through the chain length, the
degree of unsaturation, and the amount of branching of the fatty acyl
chains. In nature, variation of the degree of unsaturation is the
most common determinant of fluidity. Secondly, the amount of cho
lesterol relative to the amount of phospholipid, i.e. the C/PL molar
ratio and thirdly, the relative amounts of the different types of PL
both affect membrane fluidity. Lastly, amphipathic molecules, e.g..
naturally occurring lysophosphatides or the local anesthetics
(procaine), increase membrane fluidity. Because the lipid fluidity
is sensitive to temperature, certain organisms modify the degree of
saturation and branching of fatty acid chains to maintain their
g ^lc T^ below the ambient temperature, For example, certain
plankton require this because of their exposure to varying water
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temperatures. Erythrocytes, however, do not have this adaptive
capability, and the plasma lipoprotein composition determines the red
cell’s membrane fluidity (Cooper, 1978).
Cholesterol Interaction with Phospholipids
C.
The structural interaction of cholesterol with phospholipids is
very specific and this helps explain why alterations in membrane
cholesterol yield altered membrane fluidity, and potentially, altered
function. Cholesterol has a rigid ring structure with a flattened.
o< face, and a puckered, f3 face. The methyl groups at C-l8 and
C-19, as well as the [3 - hydroxyl at C-3 are all located on the /3
face, Phospholipids usually contain a straight saturated fatty acyl
chain at the c< carbon in glycerol, and a bent unsaturated chain at
the f3 position. The cis double bond at carbons 9 and 10 facilitates
rotation at the adjacent C - C single bonds such that gauche conformations can produce a kink in the chain, This kink creates a hydrophobic pocket which is important in the interaction with cholesterol
(Huang, 1977).
The flattened ex face of the cholesterol nucleus fits up against
the straight, saturated fatty acyl chain for optimum Van der Waals
interaction. The puckered [3 face with the two angular methyl groups
fits into the hydrophobic pocket in the unsaturated chain. Lastly,
the C-3 hydroxyl group hydrogen bonds to the carbonyl oxygen of the
unsaturated chain (Huang, 1977). In biological membranes the ideal
packing of cholesterol and phospholipid occurs at a C/PL molar ratio
= 1/2; this corresponds to approximately one cholesterol molecule
with four acyl chains (Poznansky & Czekanski, 1979). In disease
states the C/PL molar ratio is increased to 2/1; this corresponds to
one cholesterol molecule with one acyl chain,

At membrane choles-

terol levels beyond C/PL = 2/1, cholesterol is possibly located in
domains that do not influence membrane fluidity (Cooper, 1978).
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D.

Cholesterol Interaction with Band 3
It appears that the band 3 - cholesterol interaction can be di

vided into two parts:

an unspecific one and a specific one.

The

unspecific interaction results from the contributions of several
sterol molecules.

The basis of the specific interaction appears to

be a sterol binding niche on the surface of band 3.

This binds the

sterol by hydrogen bonds at its polar end (the(3 hydroxyl group),
plus a variety of hydrophobic bonds along the ring and side chain.
Sterols with slightly different structures, particularly at the polar
end and side chain, show a reduced affinity for band 3.

The choles-

terol - band 3 interaction is apparently pH independent and also independent of ionic strength,

However, the PL - band 3 interaction is

dependent upon both pH and ionic strength,

The structural basis of

the cholesterol - band 3 interaction is not proven, but is based on
the change in surface pressure when band 3 is incorporated into monolayers of different sterols (Klappauf & Schubert, 1979).
It has been shown that enrichment of human erythrocytes with
cholesterol decreases the bulk lipid fluidity (a more densely packed
bilayer leaflet) and increases the exposure of membrane proteins
(Borochov & Shinitzky, 1976).

Human erythrocytes were enriched or

depleted of cholesterol and the effects on membrane proteins assessed
by utilizing a membrane impermeable sulfhydryl labeling reagent,

In-

creased membrane cholesterol produced an increased labeling of bands
1 and 2 (spectrin), band 5 (actin), and band 3.

The increased choles-

terol had a greater effect on the intrinsic band 3 polypeptides than
on the extrinsic spectrin and actin.

A working hypothesis to explain

the band 3 movement would be a decreased lipid fluidity (increased
microviscosity) which means there are increased PL - PL interactions
(a more tightly packed bilayer).

This in turn implies decreased PL -

protein interactions plus increased lateral surface pressure which
displaces the protein towards the aqueous environment and increases
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exposure of its SH groups for labeling (Borochov et al., 1979).
Other investigators (Kirby and Green, 1980) have also increased
red cell membrane cholesterol, but checked vertical displacement of
band 3 by susceptibility to proteolytic digestion.

For membrane

cholesterol increases of 6^-103%, they found little vertical dis
placement. In view of the results with non-penetrating reagents,
they concluded band 3 undergoes conformational changes which expose
SH groups rather than produce movement of the entire molecule, This
also seems reasonable when the number of times this polypeptide
crosses the membrane is considered. Therefore, cholesterol could be
important in determining band 3's conformation by its direct contact
plus its interaction with PL molecules which alter the bulk membrane
fluidity and PL-protein interactions.
E. Altered Membrane Cholesterol Effects Membrane Functions.
It is known that cholesterol-enriched erythrocyte membranes have
changes in enzymatic activities, availability of surface receptors,
permeability, and transport.

The mechanism of these cholesterol-

induced changes in membrane properties can be: (a) an alteration in
fatty acyl chain fluidity which influences the range of motion or
potential volume available to a membrane enzyme and/or its substrate;
(b) an alteration in the boundary PL of the membrane protein (chol
esterol is excluded from this area for certain enzymes, e.g. Ca-ATPase
from the sarcoplasmic reticulum); and (c) an alteration in the position
of membrane proteins (laterally or vertically) in the bilayer
(Cooper, 1978).
1.

Effect on Enzymatic Activities
Bloj et al. (I973a,b) fed rats a cholesterol and corn oil diet to

investigate the effect of erythrocyte membrane fluidity on the activity
of three membrane-bound enzymes:
and Mg++ATPase.
inhibition.

acetylcholinesterase, (Na+K+)ATPase,

The activity was assayed by the sensitivity to F"

The unusual finding was the differential effect that the
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cholesterol rich membrane had on the enzyme's sensitivity to F
inhibition.

Cholesterol increased the sensitivity of acetylcholines

terase, decreased the sensitivity of (Na K+)ATPase, and had no effect
on Mg++ATPase.
The enzymes which phosphorylate erythrocyte membrane proteins
are also cholesterol sensitive.

Reduction of the membrane choles

terol of human erythrocytes decreases the activity of band 3 protein
kinase and spectrin kinase,

The reduced activity (5 - 30%) is ap-

parently related to the extent of cholesterol depletion (6 -20%)
(Vickers & Rathbone, 1979).
2.

Effect on Lipid Permeability — Passive Diffusion
Compounds which passively diffuse through the bilayer have their

rates of diffusion affected by its cholesterol content.

A decrease

in erythrocyte membrane cholesterol produces an increase in the
passive diffusion of glycerol, erythritol, and acetate.
to cholesterol depletion is biphasic:

The response

(a) up to 30% cholesterol

depletion produces no change in the membrane permeability and (b)
greater than 30% cholesterol depletion increases the membrane's per
meability to the above compounds (Grunze & Deuticke, 197^).

In

creasing mammalian erythrocyte membrane cholesterol to 1.6 times
normal levels produced a 10 - 20% decrease in the permeability to gly
cerol and erythritol (Deuticke & Ruska, 1976).
Several mechanisms are possible which would explain the PL cholesterol interactions which decrease bilayer permeability with
increased cholesterol content.

First, cholesterol has a condensing

effect on bilayers in the liquid-crystalline phase.

It is known that

bilayers which have undergone a condensing effect upon cholesterol
incorporation have a decreased permeability (Huang, 1977).

Alter

natively, hydrogen bond formation between the cholesterol OH and the
phospholipid 0=0 produces a belt of hydrogen bonds near the glycerol
backbone and this decreases the bilayer’s permeability (Brockerhoff,
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197U). This idea is in agreement with the concept that decreased
membrane permeability by cholesterol incorporation is due to decreased
partitioning of the solute into the membrane.

This is in contrast

to the restriction of diffusion through the bilayer (Green, 1977).
This impaired partitioning is consistent with the non-uniform effect
of cholesterol on the fatty acid chains’ decreased mobility for
carbons 1 - 10, and increased mobility for the hydrophobic core of
the bilayer.
3.

Effect on Transport — Facilitated Diffusion
The mechanisms by which cholesterol exerts its effect on protein-

mediated transport (glucose, bulk water, and anion transport ) include:
(a) alteration of the protein’s immediate PL, i.e. the boundary PL;
(b) alteration of the protein’s position in the membrane (laterally or
possibly vertically); and (c) alteration of the protein conformation
either directly by cholesterol or indirectly through the boundary PL.
Anion transport is not affected by cholesterol depletion of ery
throcytes (Grunze and Deuticke, 197U).
There have been studies investigating the effect of cholesterol
and fatty acids on liposome release of glucose (Demel et al., 1968;
Inoue, 197U). At the time, the glucose transport protein(s) (band 3
and band U.5>) was not characterized and these studies were concerned
with glucose diffusion through phospholipid bilayers, rather than
through a protein pore. Consequently, there is no reason to expect
such studies to agree with the effect of membrane cholesterol enrich
ment upon erythrocyte glucose transport.
Masiak and LeFevre (197U) investigated the effect of membrane
steroid modification on human erythrocyte glucose transport.

Choles

terol depletion produced a biphasic response: removal of 8% of the
membrane cholesterol increased D-glucose transport, but further re
moval of up to 30% decreased D-glucose transport.

This is somewhat

surprising, since removal of cholesterol would be expected to increase
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fluidity and stimulate the protein-mediated transfer process.

The

decrease in transport seems to indicate that cholesterol is important
for the physiologic functioning of band 3.

There is no effect on the

apparent Km with cholesterol removal; therefore, cholesterol removal
is independent of the carrier's affinity for glucose.

Excess membrane

cholesterol produced a U-fold decrease in the affinity for D-glucose;
the authors believe this is due to impaired accessibility.
Mien the cholesterol-depleted membrane had 3-ketosteroids added,
there was no restoration of transport activity.

However, using the

3-/3 -hydroxy steroids as replacements, transport activity returned
completely even with only partial replacement.

For example, replacing

only 2% of the removed cholesterol with stigmasterol, or 10% with 7dehydrocholesterol will result in complete transport activity.

Using

steroids with a more planar nucleus (stigmasterol) and a more bulky
side chain than cholesterol (7-dehydrocholesterol) seems to confirm
the specific band 3 - sterol interaction and its importance in glucose
transport.

Ergosterol, which combines both the above structural char

acteristics, is not effective in restoring D-glucose transport.

Some

explanation for the effects of stigmasterol, 7-dehydrocholesterol, and
ergosterol is found in the work of Klappauf and Schubert (1979).
These investigators inserted band 3 into different sterol monolayers
and measured ATT, the change in surface pressure, resulting from the
protein insertion.

They found that insertion of band 3 into monolayers

of stigmasterol and 7-dehydrocholesterol produced a A Tf that was
identical to the ATT using a cholesterol monolayer.

In contrast.

band 3 insertion into ergosterol monolayers produced only about onehalf the ATT as with a cholesterol monolayer.

Therefore, from these

results on the specific band 3 - sterol interaction, which seem to
parallel the effect on D-glucose transport, one may suspect that the
sterols immediately adjacent to band 3 profoundly affect its function
ing.

Usually one thinks of boundary PL around intrinsic membrane
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proteins, but these results seem to indicate the presence of
boundary cholesterol for band 3.
Cholesterol and Erythrocyte Morphology, Deformability, and
F.
Osmotic Fragility
The amount of membrane cholesterol has a role in maintaining the
red cell shape with its particular surface area/volume ratio.

The

biconcave disc shape allows for the minimum bending energy, i.e., the
energy required to produce a bend of a certain curvature and still
maintain the cell with its particular surface area and volume (Sheetz,
1978).

Decreasing the membrane cholesterol by using LCAT, but

maintaining the cell volume, results in a decrease in the surface
area but a constant volume. This creates smaller spherical cells
(a sphere has a minimum surface area/volume ratio). Increasing
membrane cholesterol by incubation with cholesterol-rich lecithin
dispersions results in:

(a) an increased surface area of the cell

(a 1% increase in membrane cholesterol corresponds to a 0.20 - 0.25%
increase in surface area), (b) a folded and scalloped cell margin
(spur cell), and (c) an increase in osmotic resistance or a decrease
in osmotic fragility. Cholesterol-rich cells are less deformable,
retarded within the circulation, and in passage through the spleen
undergo "slpenic conditioning". This results in a loss of membrane
and spur cell formation.

These abnormal cells are prematurely

removed from the circulation (Beck, 1977).
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2,3 PPG METABOLISM AND FUNCTION
Introduction
2,3-diphosphoglycerate (2,3 DPG) was discovered by Greenwald in
192^ as a major component of human, pig, and dog erythrocytes.

It is

the most abundant organic phosphate in mammalian erythrocytes and its
concentration varies with the specie.

For humans, the range is 3.0

to 5.7 mM (loshikawa & Minakami, 1968) and for rats, depending upon
the subspecie, it is 5.0 to 10.8 mM (Bunn et al., 197U). The second
most abundant organic phosphate is ATP, and its concentration range is
0.7 to 1.8 mM in humans (Yoshikawa & Minakami, 1968). Together,
2,3 DPG and ATP comprise (76% and 16.8% respectively) 93% of all human
erythrocyte organic phosphates. Erythrocytes are unique in having
high 2,3 DPG concentrations when compared to other tissues whose con
centrations are less than one-tenth of this (Torrance, 197U).
The high 2,3 DPG concentration, plus its large negative charge
determine the Donnan distribution of penetrating ions for erythrocytes.
This distribution is the primary effect in 2,3 DPG's modulation of red
cell enzyme activity and hemoglobin oxygen affinity (table 1). As out
lined in table 1, 2,3 DPG also has direct effects on hemoglobin, erythrocyte enzymes, and the cell membrane, Some functions will be amplified in the following discussions of erythrocyte metabolism.
The Rapoport-Luebering cycle, which constitutes the anabolic and
catabolic pathways for 2,3 DPG, has now been shown to be controlled by
one multi-functional enzyme, which catalyzes the three reactions re
lated to the metabolite, i.e. the diphosphoglycerate mutase, the
diphosphoglycerate phosphatase, and the phosphoglyceromutase reactions
(table 3).

In this last reaction 2,3 DPG functions as a cofactor.
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Table 1
A.

Functions of 2,3 DPG in Human Erythrocytes

On Hemoglobin (Hb):
Primary Effect - a preferential binding to deoxyhemoglobin
Secondary Effects -

tin

the oxygen affinity of Hb
changes in the Bohr Effect depending upon pH
I in CO^ binding to Hb
changes in the concentration of free ATP,
2,3 DPG, and Mg++

Tertiary Effect - alter the free concentration of 2,3 DPG,
which determines the cytoskeleton organiza
tion and associated membrane properties
B.

On Red Cell Enzymes:
Primary Effect - direct interaction with proteins (e.g. cyto
skeleton proteins), chelation of Mg+ , or both
Secondary Effects - inhibition
inhibition
activation
inhibition

of
of
of
of

glycolytic enzymes
2,3 DPG synthesis
phosphoglyceromutase
adenine nucleotide enzymes

C.

On the Red Cell Membrane:
Primary Effect - I weak associations of spectrin, actin, and
band U.l in the cytoskeleton
Secondary Effects - alter membrane flexibility
alter glycoprotein lateral mobility

D.

On the Donnan Distribution of Penetrating Ions:
Primary Effect - the charge and osmotic activity of 2,3 DPG
alter the Donnan distribution of penetrating
ions
Secondary Effects - I in intracellular pH
1 in intracellular Cl” and HCO^ concentrations
T in red cell water content
change the buffering capacity of red cells
Tertiary Effects - change the activities of pH dependent
metabolic pathways, e.g., glycolysis
I the oxygen affinity of hemoglobin
(adapted and modified from Duhm, 197U)

(I = decrease)
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Red Cell Metabolism
The red cell metabolism is limited compared to other body cells,
and consists of the following pathways:

Embden-Meyerhof Pathway (EMP),

Hexose Monophosphate Shunt (HMS), Rapoport-Luebering Pathway (RLP),
Methemoglobin Reductase Pathway, and purine metabolic pathways.

It

has no nucleus or ribosomal apparatus, and hence cannot synthesize
protein.

Moreover, it lacks a Krebs Cycle, mitochondria, and de novo

synthetic pathways for lipids and nucleic acids.

Although it can

metabolize fructose, mannose, and galactose, the erythrocyte physio
logically fulfills its energy requirements by metabolizing glucose
through the EMP and the HMS (Beutler, 19?8).
Embden-Meyerhof Pathway and ATP
The anaerobic EMP requires external glucose and inorganic phos
phate (Pi) and produces three important molecules — ATP, NADH, and

A.

2,3 DPG — before yielding the pyruvate and lactate which diffuse
through the membrane.

Glycolysis is responsible for 90 - 95% of the

erythrocyte’s glucose utilization and is the sole pathway for ATP
production. This production is limited to a net synthesis of 2 moles
ATP/mole of glucose consumed due to the lack of a Krebs Cycle and
mitochondrial oxidative phosphorylation. Nevertheless, this meager
ATP production (2 - 3 ni moles per liter of red cells per hour)
permits renewal of the total red cell ATP (0.7 - 1.8 mM). The ATP
functions include maintenance of glycolysis itself, membrane lipids,
+ +

++

and ion gradients through the Na K -ATPase and Ca

-ATPase pumps.

addition, by phosphorylating components of the cytoskeleton under
lying the membrane, ATP functions in maintaining the red cell disc
shape and its flexibility (Beck, 1977; Sheetz, 1977). The energy
deprived erythrocyte becomes echinocytic, then spherocytic, and
ultimately undergoes osmotic lysis. This essential role of ATP is
demonstrated in two conditions: (a) early cell death (hemolytic
anemia) when there is an ATP deficiency due to a genetic defect in

In
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glycolysis and (b) the declining erythrocyte viability resulting from
ATP depletion of stored blood (Hillman & Finch, 197U).
B.

Methemoglobin Reductase Pathway
Reducing power is generated in the production of NADH at the GAPD

step (figure U) and is utilized in the direct oxidation of NADH, the
pyruvate to lactate step, and the methemoglobin reductase pathway.
Methemoglobin is the stable form of hemoglobin where the heme iron is
found in the trivalent state and can no longer reversibly combine
with O^. The methemoglobin reductase enzyme and NADH maintain the
++
functional state. In the absence of this sys
heme iron in its Fe
tem, about 2% of circulating hemoglobin is oxidized daily to methemo
globin when oxygen is expelled as superoxide anion (Hillman & Finch,
197U; Beutler, 1978). The role of 2,3 DPG in the HMS and purine
metabolic pathways will be discussed after glycolytic control has
been considered.
C.

Key Glycolytic Control Enzymes
The three major enzymes which control glycolysis are hexokinase,
phosphofructokinase, and pyruvate kinase, The cofactors, activators.
and inhibitors are outlined in table 2 with appropriate comments.
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Embden-Meyerhof Pathway with partial Hexose Monophosphate
Pathways (Beutler, 1978)
Abbreviations: HK, hexokinase; G6P, glucose-6-phosphate; GPI, phosphoglucose isomerase; F6P, fructose-6-phosphate; PFK, phosphofructokinase; F1,6DP, fructose-1,6-diphosphate; DHAP, dihydroxyacetone
phosphate; TPI, triose phosphate isomerase; G3P, glyceraldehyde-3phosphate; GAPD, glyceraldehyde phosphate dehydrogenase; 1,3 DPG,
1,3-diphosphoglycerate; PGK, phosphoglycerate kinase; 3PG, 3-phosphoglycerate; DPGM, diphosphoglycerate mutase; 2,3 DPG, 2,3-diphosphoglycerate; DPGP, diphosphoglycerate phosphatase; Pi, inorganic
phosphate; MPGM, monophosphoglycerate mutase; 2PG, 2-phosphoglycerate;
PEP, phosphoenolpyruvate; PK, pyruvate kinase; LDH, lactate dehydro
genase; ATP, ADP, adenosine triphosphate and adenosine diphosphate;
NAD, nicotinamide adenine dinucleotide; NADP, nicotinamide adenine
dinucleotide phosphate; G6PD, glucose-6-phosphate dehydrogenase;
6PGD, 6-phosphogluconate dehydrogenase; TA, transaldolase; TK, transketolase.
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1.

Hexokinase
The hexokinase reaction is the first irreversible glycolytic

step and consequently determines the net flow through the EMP.

There

is rapid glucose transport, and even in hypoglycemic states with low
plasma glucose levels, the HK is always saturated (Grimes, 1980). HK
is the glycolytic enzyme with the lowest activity and, as the first
irreversible step, its rate determines the glycolytic rate or rate
of glucose utilization (1-2 /xmoles/ml RBC/hr.). This slow glucose
utilization is approximately 10 - 20% of the Vmax. for HK due to the
strong feedback inhibition by G6P (Rose, 1971). 2,3 DPG also inhibits
HK, but inhibition by both G6P and 2,3 DPG is relieved by increasing
++
ATP and ATP-Mg . ATP-Mg++ is the other substrate for which the
enzyme may not be saturated. Inorganic phosphorus will also relieve
G6P inhibition of HK. Because there is an inverse relationship be
tween the rate of glucose utilization and G6P levels, whatever in
creases G6P removal will increase glucose utilization (Rose, 1971)*
This is demonstrated in the stimulation of the HMS which increases
G6P removal, relaxes HK inhibition, and increases glucose utiliza
tion (Grimes, 1980).
2.

Phosphofructokinase
Similar to HK, PFK functions at a very low rate, specifically at

0.1% of its maximum capacity (Jacobasch, 1971;).

Of the three major

regulatory enzymes, PFK is the most responsive to external factors
such as pH, Pi, temperature, and pO^ (Grimes, 1980). It is particu
larly pH sensitive, where pH controls the ATP competitive inhibition
of the enzyme activity, plus the binding of F6P to PFK.

Although ATP
is also a substrate of PFK, the Km is not much affected by pH. At low
pH, ATP competitively inhibits PFKfs affinity for F6P; therefore,
increasing pH releases the ATP competitive inhibition.

Also, F6P

binding to PFK is strongly influenced by pH (Rapoport, 1968), where
increasing the pH in the physiologic range increases the enzyme^
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affinity for F6P (Brewer, 197U).

Consequently, increasing the pH

both relieves inhibition and increases enzyme affinity to promote
glycolysis.

As can be seen from Table 2, 2,3 DPG also inhibits

PFK activity in a complex manner,

The normal intracellular activity

of PFK is largely a result of positive effectors; e.g., the products
of the reaction, F1,6DP and ADP, exhibit positive feedback.

Since

ADP is an activator, and ATP is both a substrate and inhibitor, the
intracellular ADP/ATP ratio is important in determining enzyme
activity (Brewer, 19?U).

Lastly, G6P, G1,6DP, NH^ , AMP, and Pi are

all activators, where AMP and Pi relieve ATP inhibition (Grimes, 1980).

3.

Pyruvate Kinase
Pyruvate kinase regulates the distal part of the glycolytic

pathway or the third irreversible reaction.

Its influence is not on

the overall glycolytic rate, but rather on distributing the substrate
flow between the main pathway and the Rapoport-Luebering Cycle.
doing so, it controls the ratio of ATP to 2,3 DPG.

In

Moreover, it

contributes to the control of NADH levels by the production of pyruvate
(Brewer et al., 19?U; Badwey et al., 1977).
PK has 5>0 times the capacity required to account for the rate of
lactate production, and is normally unsaturated with respect to its
two substrates, .ADP and PEP.

The rate of PK activity is proportional

to (PEP) (ADP/ATP) (Rose, 1971).

Consequently, if the glycolytic

flux increases to produce increased PEP levels, PK activity can also
increase.

However, it may do so with a time lag of physiological

significance.
The enzyme has some unique allosteric properties mediated by
F1,6DP.

Normally it has a slightly sigmoidal saturation curve for

PEP at saturating levels of ADP.

Upon the addition of F1,6DP this

curve becomes a rectangular hyperbola with greatly reduced Km and
slightly higher Vmax.

PK which is only US hours old has appreciably

less activity due to oxidation.

Such pyruvate kinase, or PK which
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has been intentionally oxidized to the point of no detectable
activity, will show normal or hyperbolic kinetics in the presence
of F1,6DP. The ability of an allosteric modifier to overcome the
effects of enzyme oxidation and restore maximal enzyme activity is
apparently a unique phenomena (Badwey et al., 1977).
Similar to PFK, the ATP inhibition of PK is also pH sensitive,
so that increasing the pH releases the inhibition. Pi also relieves
+
the ATP inhibition. The K ion functions by increasing the enzyme’s
affinity for ADP (Grimes, 1980).
P.

Glycolytic Control
The erythrocyte can increase glucose consumption several fold

and thereby increase its ATP and 2,3 PPG levels through the modula
tion of the three irreversible, rate limiting enzymes — HK, PFK,
and PK. These enzymes normally operate in a partially inhibited
condition. Therefore, release of this inhibition stimulates gly
colysis and further inhibition inhibits glycolysis. It should be
noted that in vivo control of glycolysis as well as 2,3 PPG and ATP
production is not completely understood.
Red cell glycolytic control is studied by acid precipitation of
the blood which halts all enzyme activity; then the levels of each
glycolytic intermediate are compared with standard values.

This will

provide information about the status of the enzyme related to that
intermediate at the time of precipitation; e.g., if an enzyme is
inhibited, then its product levels decrease and the reactant levels
increase. This is graphically expressed in a "cross-over plot",
illustrated below, where the cross-over point of the graph indicates
the enzyme most profoundly affected by a stress e.g., a pH change
(Brewer, et al., 1976).
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Values of intermediates
2.00

Change in level
of

@ different conditions,
e.g. pH = 7.8

I oo

intermediate

Standard values assigned

o

a value of 100 @ pH = 7.U

Different Glycolytic Intermediates
Jacobasch et al. (197U) have found that an overall view of
glycolytic regulation is possible if the pathway is considered in
two sections: the HK-PFK section and the GAPD-LDH section, A discussion of this second section is intimately connected with the control of 2,3 DPG levels, less concerned with overall glycolytic flow
(as noted under the pyruvate kinase section), and will be discussed
later. As mentioned above, alteration of the glycolytic rate is
achieved by modulating the activity of three key enzymes, either
directly or indirectly, through a number of effectors:
2,3 DPG, p02, and temperature.

ATP, pH, Pi,

1.

ATP
An increase in ATP above normal levels means an increase in the
ATP-Mg++ complex — the substrate for both HK and PFK. Both ATP and
ATP-Mg++ competitively relieve the inhibition of G6P on HK; however,
that increased activity of HK will increase G6P levels and inhibit
the enzyme again. The ATP inhibits PFK, and this enzyme has a greater
affinity for ATP-Mg++ than HK. The net effect of this interplay is a
decline in glucose consumption when ATP concentrations increase above
normal. One might postulate a simple negative feedback for overall
control of glycolysis in which increased ATP inhibits PFK and decreas
ed ATP releases that inhibition.

However, the regulation is not that

simple, since there is some evidence that AMP levels control PFK
activity.

Nevertheless, ATP is essential for PFK activity and the
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enzyme appears to be a key control point for glycolysis as determined
by Nakao and Nakayama (1980).

They examined the activities of 15

erythrocyte enzymes, including all the glycolytic enzymes, of cells
stored for 8 weeks at ii°C.

The activities of all the glycolytic

enzymes except PFK were in the normal range, and the decrease in PFK
activity paralleled the decrease in ATP levels.

These investigators

concluded that ATP is essential for PFK activity and the maintenance
of glycolysis.
In contrast, there is evidence in blowfly muscle that performance
of work leads to a 100 fold increase in the glycolytic rate, only a
10% decrease in ATP levels, but a 250% increase in AMP (Sacktor &
Hurlbutt, 1966).

Although this is in muscle, a role for fine control

by which AMP tops up a declining ATP level has been proposed
(Newsholme & Start, 1973).

It is known that:
(ATP) (AMP)

fTAMP + ATP
2 ADP^
adenylate
kinase

K ab
>, =

(ADP)2

First, when ATP is utilized in energy requiring processes resulting
in ADP formation, the AMP concentration rises due to rapid equilibrium
via adenylate kinase, Since the concentration of ATP is approximately £0 times that of AMP at equilibrium, a small fractional
decrease in (ATP) will cause a several fold increase in (AMP).
Therefore, changes in AMP concentration amplify small changes in ATP
concentration • Secondly, when AMP relieves the ATP inhibition of PFK,
it does so because PFK responds to fractional changes in (AMP) rather
than absolute concentration. Hence, the small changes in (AT0 yield
large fractional changes in (AMP) to which the PFK is sensitive, and
in this way maintain ATP levels, Such a mechanism could easily be
integrated with the regulation of ATP levels by PFK. The writer
believes this may be true, because Nakao and Nakayama noted that
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adenylate kinase was one of the few other enzymes whose activity
decreased. The significance of 2,3 DPG in controlling MP and ATP
levels will be discussed in the purine metabolism section.
2.

pH
By utilizing the cross-over plot technique, the influence of pH
on the glycolytic rate has been investigated. Increasing the pH increases glucose consumption and decreasing the pH causes the opposite effect. At alkaline conditions (pH = 7.8), the PFK activity
increases due to the pH mediated release of ATP inhibition, the
increased affinity for F6P, and the decreasing ATP concentration;
ATP is acid stable and alkaline labile. The increased PFK activity
will decrease G6P levels and consequently relieve HK inhibition; this
increased HK activity occurs despite the lowered ATP levels.

In

summary, at alkaline pH: (1) HK and PFK activities increase,
(2) glycolytic intermediates before PFK decrease and those downstream
thru PEP increase, (3) ATP levels decrease, while ADP levels increase
and (U) pyruvate levels do not change. At acid pH (pH = 7.0) :
(1) HK and PFK activities decrease, (2) the levels of glycolytic
intermediates on each side of PFK are reversed c.f. alkaline condi
tions, (3) the ATP levels do not change while ADP increases, and
(U) the PK activity increases with concomitant increases in pyruvate
levels (Minakami 8c Yoshikawa, 1966).
3.

Pi
At physiologic pH, an increase in Pi increases the rate of gly

colysis (Minakami & Yoshikawa, 1965), while levels of Pi below the
physiologic range, induced by dietary manipulations, will decrease
the glycolytic rate plus the ATP and 2,3 DPG levels (Rapoport, 1968;
Jacobasch et al., 197U). Therefore, apparently Pi can stimulate
glycolysis independently of pH (Grimes, 1980).

The mechanism of in

creased glycolytic rate with increased Pi is release of ATP inhibi
tion of PFK, and possibly relief of HK inhibition. This mechanism of
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glycolytic stimulation by increasing Pi concentration, does however,
depend on pH.

This is seen by comparing: the percentage change in

the glycolytic intermediates, the ATP levels and the ADP levels, in
going from Pi = 0 to Pi = 30 nM @ pH = 7.0 to the corresponding
percentage changes in going from Pi = 0 to Pi = 30 hM @ pH = 8.0.
Although the percentage change for a given intermediate is in the
same direction, the size of the change differs @ pH = 7.0 and pH = 8.0
(Minakami & Yoshikawa, 1966).
E.

Relationship of the HMS to Glycolysis, ATP, and 2,3 PPG
The HMS branches off glycolysis at G6P with the first two steps

being essentially irreversible, while the remaining steps are re
versible. This pathway performs two primary functions: (l) the
generation of NADPH from NADH to maintain reduced glutathione and
protein SH groups; this protects proteins from denaturation, e.g.,
globin; (2) the production of ribose-5-phosphate for utilization in
nucleotide synthesis or cyclization back into glycolysis at F6P and
GAPD (Figure k)•
The physiologic activities of G6PD and 6PGD are only 0.2% of the
maximal potential activities, i.e., their activity is strongly reg
ulated by G6PD whose activity is controlled by the NADP+/NADPH ratio.
The Km of G6PD for NADP+ is 3 - U ^ which is well above the 1yxM
concentration of NADP+ in the resting cell. Therefore, G6PD and the
HMS activity will be sensitive to small changes in the NADP+ levels.
Moreover, NADPH substantially inhibits G6PD at physiologic levels
4.
along with ATP. Hence, anything which increases the NADP /NADPH ratio
will increase the HMS activity (Grimes, 1980). 6PGD is not the rate
limiting enzyme for the HMS, so although it is inhibited by 2,3 DPG,
NADPH, and ATP, these effectors will not control the pathway^
activity (Yoshida, 1973).

Two key reversible enzymes, transketolase

and transaldolase, are significantly inhibited by 2,3 DPG (Dische,
1963).
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The pentose phosphate pathway activity siphons off approxi
mately 10% of the erythrocyte's glucose consumption (Murphy, I960).
Substrate flow through the shunt can be increased and the influence
of this on glucose consumption as well as ATP and 2,3 DPO levels has
not been completely studied. Potentially, since the HMS bypasses the
PFK regulatory step and feeds into the lower half of the EMP, in
creases in HMS flow would contribute to increased ATP and 2,3 PPG
levels (Brewer, 197U).

This capability will be seen in purine

metabolism, where inosine entering the HMS generates ribose-5-phosphate and results in increased 2,3 DPG levels.

Secondly, methylene

blue oxidizes NADPH to NADP, increases the NADP+/NADPH ratio, stim
ulates G6PD activity, and thereby accelerates the HMS. This produces
increased glucose consumption and elevated 2,3 DPG levels.
F.
2,3 DPG and ATP in Purine Metabolism
The cold storage of erythrocytes results in a decline of ATP and
2,3 DPG. Attempts to prevent this decline or regenerate these
physiologically important metabolites afterward have increased under
standing of erythrocyte purine metabolism. Two factors which have
received the most attention are the purine nucleotides in the sus
pending medium and its pH. The rate of glucose consumption of blood
stored at 1±0C is < 1% of that at 37°C, continuously declines, and
eventually stops. The slow rate is clearly a function of the low
temperature, but the decline is brought about by a decrease in pH
through lactate production.

If the pH of the blood is maintained by

serial addition of NaHCO^, then the initial rate of glucose consump
tion is maintained, and this sustains the ATP at the higher level
(Grimes, 1960). Although the decreasing metabolic function accounts
for a fall in ATP, when ATP is regenerated there is not a concomitant
improvement in cell viability.

Such results suggest that other

changes occur which are not reversible by rejuvenating the phosphate
ester pool (Wood & Beutler, 1967).
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ATP and 2,3 DPG each decline at their characteristic rates,
e.g., intracellular ATP declines to 65, 5U, 28, and 0 percent of the
blood content after 2, 3, U, and 8 weeks of storage respectively; by
comparison, 2,3 DPG falls to 25% of its initial value after 2 weeks
(Schafer & Bartlett, 1961). Hence, the decline in 2,3 PPG concentration is faster than that of ATP.

A factor which governs the rate of

this decline is the pH of the storage medium, because 2,3 PPG is acid
labile while ATP tends to be acid stable (Pawson et al., 1972). The
two standard preservative mixtures are: AGP (citric acid, sodium
citrate, and dextrose) and GPP (citrate, phosphate, and dextrose).
When cells are stored in either ACD or CPD @ 3°C and pH< 7*0, there
is decreased 2,3 PPG and increased ATP, while @ pHci7.il the 2,3 PPG
increases and the ATP is unstable. This phenomena can be explained
by the decreasing pH of stored blood which inhibits glycolysis and
2,3 PPG synthesis, plus accelerated destruction of 2,3 PPG by PPGP
whose activity is increased at acid pH. Therefore, since ATP and
2,3 PPG respond differently to acidity and basicity, an optimal pH
for maintenance is desirable. The CPD-blood mixture is better for
the preservation of 2,3 PPG than the ACD-blood mixture, because the
former has a higher pH — 7.2 (Grimes, 1980). ATP preservation seems
to be best maintained by base or nucleotide addition to the medium.
ATP and the nucleotide pool of red cells in storage decline by
ABP
AMP—*~IMP —^Inosine —*-Hypodrainage to hypoxanthine: ATP
xanthine. The control of the irreversible degredative step AMP—►IMP
will be considered shortly, but initially we will look at the bene
ficial role of adenine and nucleosides in the medium for maintaining
the erythrocyte pool (see Fig. 5), i.e • > the supply side.
Inosine, inosine and adenine, and adenosine have varying effects
on red cell 2,3 PPG and ATP levels, probably due to their different
mechanisms of action.

Blood cold-stored in ACD for 8 weeks and in

cubated for 3 hours § 37°C with different nucleosides yielded these
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Fig. 5

Metabolic pathways of adenine, adenosine, and related
nucleosides/nucleotides in the human erythrocyte
(l) adenosine deaminase; (2) nucleoside phosphorylase;
(3) phosphoribomutase (PRM); (ii) phosphoribosylpyrophosphate synthetase
(PRPP synthetase); (5) adenine phosphoribosyltransferase (adenine PRT);
(6) adenosine kinase; (?) AMP deaminase; (8) adenylate kinase;
(9) hypoxanthine phosphoribosyl transferase (hypoxanthine PRT).

*

2,3 DPG is an effector.

] exchanges with extracellular medium
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representative results: (a) inosine alone hardly affected the ATP
level, but raised the 2,3 DPG level from 1.5 to 7h /mole/dl of whole
blood; (b) inosine and adenine raised ATP from 1.5 to 27.b /imole/dl
of whole blood and raised 2,3 DPG to U3.5 /umole/dl of whole blood
(Nakao et al., 1959; Shafer & Bartlett, 1962; Strumia & Strumia, 1972;
Bartlett, 1972). Purine nucleosides or free base can increase red
cell ATP levels in two ways, namely glycolysis and nucleotide synthe
sis.

The nucleosides adenosine, inosine, and guanosine provide

ribose-5-phosphate (R-5-P) which can be utilized in glycolysis via
TK and TA (see Fig. h)• Since ribose-5-phosphate enters glycolysis
below the ATP requiring steps of hexokinase and phosphofructokinase,
yet above the ATP producing steps of PGK and PK, this metabolite can
maintain glycolysis economically. Secondly, R-5-P can be used to
produce PRPP in which AMP is also generated. The AMP is converted
to ADP via adenylate kinase and the ADP can then be utilized in
glycolysis for ATP production; this offers no benefit to the total
nucleotide pool (Grimes, 19S0). Adenine can be utilized to maintain
ATP by direct nucleotide synthesis in reaction 5 in Figure 5* It is
now understandable why inosine alone only elevates 2,3 DPG levels —
only glycolysis is promoted with the concomitant 2,3 DPG synthesis.
Adenine and inosine will allow both glycolysis and nucleotide synthe
sis to occur and hence elevate both 2,3 DPG and ATP respectively.
As was noted earlier in the section on glycolytic control, Nakao
and Nakayama (1980) have shown that the one glycolytic enzyme whose
activity declines in cold storage, PFK, exhibits a decline paralleling
the decline in ATP levels. They also showed that adenine plus inosine
added to the preservation medium prevented this decline in ATP levels
and PFK activity, In contrast, either adenine or inosine alone did
not.

They concluded that the decrease in glycolytic activity during

preservation was due to a loss of PFK activity which in turn was due
to a decrease in ATP.
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It should be noted that the two key enzymes for maintaining
MP levels (and hence ATP) by nucleotide synthesis — PRPP synthetase
and adenine PRT — are inhibited by 2,3 DPG (see Fig. 5).

PRPP

synthetase is composed of a number of subunits which self associate
into groups in the presence of Mg++ATP.

The inhibitory effect of

2,3 DPG acts by blocking subunit association and dissociating the
enzyme (Becker et al., 1977).

2,3 DPG affects adenine PRT activity

by competitive inhibition with PRPP (Yip & Bales, 1975).

Therefore,

2,3 DPG has a regulatory role in the supply side of the AMP, aDP,
and ATP nucleotide pool, at least as far as nucleotide synthesis is
concerned.
Blood cold stored with adenosine rather than with inosine is
more effective in regenerating ATP (Overgaard-Hansen et al., 1957;
Molison & Robinson, 1959; Shafer & Bartlett, 1962).

Presumably the

adenosine like inosine, primed glycolysis as mentioned above,

How-

ever, the enhanced effect was attributed to direct phosphorylation
of adenosine to AMP by adenosine kinase (see Fig. 5) and the adenine
nucleotide pool is maintained in part by endogenous adenosine (Schroder
et al., 1972; Snyder & Henderson, 1973; Parks & Brown, 1973).

The

adenosine kinase has less activity but greater substrate affinity c.f.
adenosine deaminase, so theoretically there should be competition
between them for adenosine.

Investigation of two different genetic

anomalies has shown that patients with enhanced deaminase activity
had low ATP levels, while those which lacked deaminase activity had
increased ATP and total nucleotide levels.

This suggests that the

availability of adenosine, and balanced competition for it between
adenosine kinase and deaminase, are necessary for normal maintenance
of the adenine nucleotide pool (Paglia et al., 1977).
Erythrocytes lack the de novo synthesis of purine nucleotides
to produce IMP and the adenylsuccinate synthetase to convert IMP to
AMP (Lowry & Dorfman, 1970).

As mentioned earlier, there is an AMP

6k

deaminase which causes irreversible disappearance of adenine nucleo
tides .

Therefore, to account for the maintenance of adenine nucleo

tide levels and their observed turnover (Bishop, 1961), adenine
nucleotide precursors from an external source are necessary,

Adeno-

sine taken up from the liver and converted to AMP by adenosine kinase,
as noted in the previous paragraph, is the most likely mechanism
(Lerner & Lowry, 197U).
Based on the high maximal activity of the AMP deaminase (Sasaki
et al., 1976) and the total concentration of adenine nucleotides per
cell, it is crucial to control AMP deaminase to maintain the biological half-life of these metabolites,

AMP deaminase is an allosteric

enzyme with three effectors — AMP, ATP, and 2,3 DPG — which influ
ence its activity (Lian & Harkness, 197U). The sigmoidal relationship
between the velocity of AMP deamination vs. the concentration of AMP
is affected by ATP and 2,3 DPG such that these effectors counteract
one another.

Specifically, ATP changes the sigmoidal curve to a

hyperbolic one without a change in the maximal velocity.
ATP accelerates AMP deaminase.

Therefore,

Conversely, 2,3 DPG shifts the sig

moidal curve to higher AMP concentrations; i.e. it inhibits AMP
catabolization (Askari 8c Franklin, 1965).

At the physiologic concen-

trations of AMP (0.02 - 0.03 mM) the half-life of the adenine nucleotide pool is prolonged in the presence of 2,3 DPG c.f. ATP alone.
This indicates 2,3 DPG is an important factor in the repression of
AMP deaminase.

The allosteric nature of human erythrocyte AMP de

aminase changes in response to small environmental changes, e.g.,
phosphatidyl serine (PS) inhibits its activity.

It is noteworthy

that PS is a major phospholipid in the inner erythrocyte membrane
half, and that a significant percentage of the total AMP deaminase
is found in the membrane fraction after hemolysis (Rao et al., 1968).
There is no proof, however, that the membrane bound enzyme is
inactive.
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G.

Metabolism of 2,3 DPG
Rapoport and Luebering (1950* 1951) were the first who claimed

that intracellular 2,3 DPG levels were maintained by two enzymes —
DPGM and DPGP (see Fig. 6).

These two enzyme activities have been

studied separately by a number of investigators (Rose, 1968; Harkness
et al., 1969; Rose et al., 1970).

DPGM and DPGP activities are now

known to be found on one molecule, i.e., the traditional DPGM enzyme
of Rapoport and Luebering manifests both mutase and phosphatase
capability (Rosa et al., 1973; Rose & Dube, 1976a; Hass Sc Miller,
1975; Harkness et al., 1977).
ity (Rosa et al., 1975).

This molecule also exhibits PGM activ

Consequently, it is now evident that the

Rapoport-Luebering Cycle no longer exists, DPGP is not a separate
enzyme, and one trifunctional molecule exists with DPGM, DPGP, and
PGM activities (Rose & Whalen, 1973; Sasaki et al., 1975; Kappel &
Hass, 1976).

The glycolytic enzyme PGM also exhibits DPGM and DPGP

activities at low levels (Chiba & Sasaki, 1978; Rose & Dube, 1976b;
Laforet et al., 197U).

In conclusion, there are two enzymes, each

catalyzing the same three reactions, although at different relative
rates.

First, DPGM, renamed DPG synthase or biphosphoglyceromutase-

phosphatase, has two principle activities — DPGM and DPGP;

it also

has PGM activity, which probably does not contribute to glycolytic
flow.

The PGM enzyme is essentially a glycolytic enzyme and over 90%

of the DPGM and DPGP activities reside in DPG synthase rather than
in PGM (Chiba & Sasaki, 1978).
Despite these differences in function, the DPG synthase and PGM
exhibit striking similarities:

(1) each is composed of two subunits;

(2) they have similar native molecular weights; and (3) both exhibit
a high degree of similarity in primary, secondary, and tertiary
structure (Hass et al., 1978; Kappel & Hass, 1976).

This similarity

may be carried over to the enzyme's active site since there is known
to

be amino acid sequence homology for the active site in human DPGM

and yeast PGM (Haggarty Sc Fothergill, 1980).
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Glucose

i
i

1,l-P^-Glycerate
DPGM

A

ADP

(i)

Mv
++

2y l-P^-Glycerate

PGK
DPGP

ATP

(2)
3-P-Gly cerate

(3)

1

PGM or MPGM

2-P-Glycerate
i

I

Lactate

(1)

2,3 DPG + 3PG

1,3 DPG + 3PG
DPG mutase

(2)

^ 3PG + Pi

2,3 DPG ♦ H20
DPG phosphatase

(3)

Fig. 6
Note:

^ 2,3 DPG + 2PG
pho spho gly cerate
mutase or
monophosphoglycerate mutase MPGM

2,3 DPG + 3PG -<■

Metabolism of 2,3 DPG
(1) & (2) are no longer separate enzymes.

6?

The three enzymatic activities of biphosphoglycerorrmtasephosphatase are exhibited at a common site where an amino group is
essential for binding biphosphoglycerates.

Complete inactivation of

all three enzymatic activities is achieved by the modification of
this one amino group, although the enzyme is composed of two subunits
(Hass et al., 1976; Ikura et al., 1976),

This result may be ex

plained by the binding of a ligand to one subunit (modification of
the amino group) and thereby inducing conformational changes in the
neighboring subunit which determines that second subunit’s binding
ability (Levitzki et al • 9 1971).
The reaction mechanism for DPGM activity is a bimolecular
reaction which forms a ternary complex and proceeds in an ordered
sequential manner. Specifically, 1,3 DPG binds the enzyme first,
and then 3PG binds to produce a ternary complex.

The phosphate group

in position one in 1,3 DPG is transferred to 3PG to produce 2,3 DPG.
1,3 DPG is now 3PG and leaves the enzyme; then 2,3 DPG leaves.

This

sequential pathway makes it appear that there are separate sites
for the two substrates (Rose, 1970).
1,3 DPG

Enzyme site

(i)

3PG

3PG

2,3 DPG

i

t

t

(2)

(1)

(2)

Ikura et al. (1976) have proposed a model which incorporates
the following features: a common site for enzymatic activities, two
binding sites for substrates, and most of the characteristics of
biphosphoglyceromutase-phosphatase (Table 3). The model consists of
one binding site exclusively for biphosphoglycerates (bi PG) and
another exclusively for monophosphoglycerates (mono PG).

Monophos-

phoglycerates can bind to the biphosphoglycerate site but with lower
affinity.
bi PG site
mono PG site
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"When the bi PG and mono PG sites are occupied as shown:
1,3 DPG

3PG

the enzyme exhibits DPGM activity.

follows the ordered sequential pathway, and forms a ternary complex
(Rose, 1970). DPGM activity will be competitively inhibited by
2,3 DPG when it binds to the bi PG site.
If the bi PG and mono PG sites are occupied as shown:
2,3 DPG

3PG or 2PG

the enzyme exhibits PGM

activity to produce 2 PGA or 3PG.
If the bi PG and mono PG sites are occupied as shown:
2,3 DPG

nothing or an
activator^

the enzyme is converted to DPGP activity to yield 3PG.

It is known

that the mono PG site must be filled by 2,3 DPG for yeast DPGM to
function as a phosphatase; whether the same holds true for humans is
unknown. The inhibitory effect of 3PG and 2PG on DPGP activity
(Table 3) is due to the conversion of the enzyme into a PGM when they
bind to the mono PG site. Pi and 2-P-glycolate interact with the
mono PG site to activate the DPGP activity, but inhibit the DPGM and
PGM activities (Table 3). Therefore, the kind of reaction which
occurs depends on the affinities of substrates for the different
sites, substrate concentrations, and effectors, e.g. Pi.
1.
DPGM
DPGM is responsible for 2,3 DPG synthesis (maximum of 200 /unole/
ml red cells/hr.) (Sasaki et al., 1975) and utilizes two substrates:
1,3 DPG and 3PG. The physiologic concentration of 3PG is approximate
ly 100 times the enzyme's Km for 3PG and consequently the enzyme is
saturated with this substrate (Chiba & Sasaki, 1978).

By comparison.
the physiologic concentration of 1,3 DPG (0.6 - 0.8yu.M) (Rose, 1968,
1970) is approximately 1/10 of the enzyme's Km for 1,3 DPG;
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consequently, the rate of 2,3 DPG synthesis will be affected by
anything which affects 1,3 DPG levels.

The intracellular role of

3PG and Pi are probably minor in affecting 2,3 DPG levels (Rose, 1968).
However, of all the inhibitors, the reaction product of 2,3 DPG
strongly inhibits the DPGM and at physiologic concentrations this
inhibition amounts to 99% (Gerlach & Duhm, 1972). Therefore, the
rate of the enzyme in the cell will be determined mainly by the
1,3 DPG and 2,3 DPG levels (Rose, 1970).
2.
DPGP
DPGP has a very low activity in erythrocytes and converts 2,3 DPG
to 3PG at a rate of 60 ymmole/ral RBC/hr. (red blood cells = RBC)
without any activators present.

However, Cl” and other anions, as

well as Pi, are activators (Rose & Liebowitz, 1970).

With physio

logic concentrations of KOI and Pi, the activity rises to 8U0 /xmole/
ml RBC/hr. (Rose, 1970; Rose & Liebowitz, 1970). It is unlikely that
Pi is an important regulatory factor alone, since Pi in the absence
of chloride has very little affect on the rate (Rose, 1970). DPGP
is strongly activated by 2-phosphoglycolate (Rose, 1970; Rose Sc
Liebowitz, 1970) and pyruvate kinase catalyzes its formation from
glycolate and ATP (Rose, 1976). Moreover, there is a very high activ
ity of a phosphoglycolate phosphatase in human erythrocytes (Badwey,
1977). However, the role of 2-P-glycolate under physiologic con
ditions has not been determined.
3.

PGK
The PGK activity is high and physiologically it operates at an

equilibrium which is well towards the formation of 3PG (Grimes, 1980).
Within physiologic concentrations of ATP and 2,3 DPG, the enzyme is
inhibited by both compounds. Furthermore, 2,3 DPG inhibition is the
most potent on a percentage basis, when compared with 2,3 DPG inhi
bition of HK, PFK, and PK (Ponce et al., 1971).

PGK competes with
DPGM for the common substrate 1,3 DPG, and this will be discussed
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in the section, control of 2,3 DPG levels
H.

Control of 2,3 DPG Levels
There are a number of physiologic factors which can alter

erythrocyte 2,3 DPG levels, e.g., hypoxia, acid/base imbalance,
altitude, and exercise. These primary stimuli will not be considered, but rather the intracellular control mechanisms will be
discussed.
Glycolytic regulation is probably the major factor in con
trolling 2,3 DPG levels, while the 2,3 DPG shunt enzymatic activities
are a modulating factor (Brewer, 197U).

PFK, HK, and PK are the
glycolytic control points for regulating the primary determinant of
2.3 DPG levels — the 1,3 DPG concentration (Torrance, 197U). This
is true because normal physiologic concentrations of 1,3 DPG are not
sufficient to saturate DPG synthase, and therefore any increases in
1.3 DPG concentration will increase DPGM activity. As we noted
earlier, PK does not influence the overall glycolytic rate, but does
control substrate flow between the shunt and glycolysis. Specifically,
it is well known that PK deficiency yields relatively high 2,3 DPG
levels and low ATP levels (Brewer et al., 197U). By comparison,
Zurcher et al.^(1965) have shown that individuals with high hereditary
ATP levels had relatively low 2,3 DPG levels. Hence, to some extent
PK activity determines the 2,3 DPG to ATP ratio. Also contributing
to this ratio would be the competition between PGK and DPGM for their
common substrate 1,3 DPG. The regulation is fairly complex. The PGK
reaction yields ATP and 3PG, while the DPGM reaction yields 2,3 DPG.
ATP inhibits PGK; 2,3 DPG inhibits the DPGM; but 3PG is a cofactor
for the synthesis of 2,3 DPG. Moreover, the concentration of 2,3 DPG
is approximately 100 times the concentration of 3PG. This interconnection between the products of one reaction as the cofactor of
the other reaction, plus product feedback inhibition for each reaction,
allows for self regulation of ATP and 2,3 DPG levels (Grimes, 1980).
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Lastly, the DPGM and DPGP activities are certainly important.

The

two major intracellular effectors acting on glycolysis to control
1,3 PPG concentrations and hence 2,3 PPG levels are pH and Pi
(Torrance, 197li).
Estimates for the percentage of the glycolytic flux passing
through the 2,3 PPG bypass seems to be below 25% and is dependent
on the pH and Pi concentration.

Momsen and Vestergaard-Bogind (1978)

have shown it to be 10 - 15% at pH = 7.0.

The steady state bypass

flow is 2h% at pH = 7.U and 12% at pH “ 7•Oh according to Rapoport
et al. (1977).

A number of investigators believe that PPGP is the

rate determining reaction of the bypass because of its low activity.
Therefore, a determination of its physiologic, steady state rate
should give the percentage of the glycolytic flux through the bypass
(Rapoport et al., 1977; Hamasaki & Minakami, 1972).

Pi is a known

activator of the PPGP reaction; Momsen and Vestergaard-Bogind (1978)
have concluded that the PPGP is activated by Pi in intact cells
and that the percentage of glycolytic flow passing through the bypass
is a function of the Pi concentration.
1.

2,3 PPG Synthesis
Effect of pH:
Elevation of extracellular pH above 7.U either in vitro or in

vivo produces increased 2,3 PPG, while a lowering of pH has the
reverse effect (Puhm & Gerlach, 197U).
increased pH effect are:

The mechanisms of the

(l) an increase in PFK activity and 2,3 PPG

levels (Tauri et al., 1980) via an increase in 1,3 PPG levels
(Minakami et al., 196U); (2) increased PPGM activity (Rose, 1973) and
decreased PPGP activity (Rose & Liebowitz, 1970); and (3) an increase
in free 2,3 PPG because of its decreased affinity for hemoglobin
(Benesch et al • j 1969). The first factor is the most important,
although the second may contribute significantly.

The increase in

2,3 PPG from factor 3 would inhibit PPGM activity and decrease syn-
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thesis, but this effect is probably disguised in factors 1 and 2
(Chiba & Sasaki, 1978).
Effect of Pi:
The in vivo effect of changes in serum Pi on 2,3 PPG levels is
observed by a 10 - 20% increase upon administration of a single oral
dose of 30 - 60 nmoles of Pi (Brain & Card, 1972).

Presumably the

mechanism of its effect would be release of PFK inhibition and per
haps HK inhibition, plus acting as a substrate for the PGD reaction
which produces 1,3 DPG.
2.

2,3 DPG Degredation
Effect of pH and Pi:
Decreasing the intracellular pH produces lower 2,3 DPG levels

and the mechanism may be analogous to that for an increase in pH.
The glycolytic intermediate profile for hereditary PFK deficiency
and different acquired acidotic conditions (e.g. diabetic keto
acidosis) are very similar, where 2,3 DPG and F1,6DP decrease in
parallel.

There is a cross-over point in each profile at PFK, and

PFK shows a decreased activity for pH = 6.9 to 7.U.

Consequently,

it seems that acidosis yields a decreased PFK activity, and a con
comitant decrease in downstream intermediates including 2,3 DPG
(Tauri et al., 1980).
Momsen and Vestergaard-Bogind found that, at least qualitatively,
the net breakdown of 2,3 DPG is explained by declining 1,3 DPG levels
at pH = 7.0.

They noted the Pi concentration increased at low pH

and increased the rate of 2,3 DPG degredation.

The new lower rate of

degredation became constant after two hours, and was attributed to
decreased 2,3 DPG concentrations which deinhibited DPGM, but increased
Pi concentrations which activated DPGP.
By contrast, Rapoport et al. (1977) found DPGM activity to be
more important than 1,3 DPG levels, DPGP, and Pi.
found for the pH = 6„6 - 7.U range that:

These investigators

(a) 1,3 DPG levels did not

7U

decrease at low pH; (b) DPGP activity was constant and independent
of pH; (c) intracellular pH = 7.2 resulted in constant or slightly
increased 2,3 DPG levels; and (d) intracellular pH = 6.8 yielded
decreased 2,3 DPG levels.

The DPGM activity was almost completely

shut off at pH = 6.8, but normal at pH = 7.2.

Coupled with this

decrease in 2,3 DPG synthesis at low pH, it has been noted that there
may be increased competition for 1,3 DPG by ADP activated PGK
(Rapoport et al., 196U Gerlach et al., 1970).
3.

Self-limiting Effects of 2,3 DPG
2,3 DPG has at least four mechanisms whereby it can inhibit its

own synthesis.

Elevated 2,3 DPG levels can directly inhibit glyco

lytic enzymes (Ponce et al., 1971; Beutler et al., 197U).

Secondly,

2,3 DPG is an impermeable anion which will shift H+ into the cell to
maintain the Dorman equilibrium.

This will decrease the intracellular

pH and thereby decrease glycolysis and 1,3 DPG levels (Duhm, 1972).
Thirdly, 2,3 DPG synthesis has occurred at the expense of ATP pro
duction via PGK; therefore, the ADP/ATP ratio will eventually in
crease to stimulate PGK at the expense of 2,3 DPG (Grimes, 1980).
One should also note that increasing the ADP/ATP ratio will stimulate
PK, since it is unsaturated with ADP. This enzyme, as we have noted,
shifts substrate flow between the bypass and glycolysis. Fourthly,
DPGM is strongly inhibited by 2,3 DPG. Next, we will look at the
relative role of these first two mechanisms.
Except for TPI smd enolase, all the glycolytic enzymes through
pyruvate are inhibited by 2,3 DPG (Beutler, 1978). Of these, four of
particular importance to glycolytic and 2,3 DPG regulation are HK,
PFK, PK, and PGK.

Ponce et al. (1971) has found that for the physio

logic range of 2,3 DPG, these four enzymes are inhibited in the fol
lowing sequence:

PGK > PK > HK > PFK; the percentage inhibition is

78%, 73%, 37%j and 12% respectively. Duhm investigated the role of
2,3 DPG inhibition of glycolysis in cells with five times the normal

7£

amount and concluded that:

(a) 50% of the inhibition was accounted

for by a direct inhibitory effect of 2,3 DPG on HK, though probably
not on PK and (b) the remaining part of the inhibition was due to a
2,3 DPG induced decrease in pH which inhibited the PFK enzyme
(Duhm, 197$).

OBJECTIVES OF THE STUDY
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An increase in dietary cholesterol and cholic acid will elevate
serum cholesterol levels more than either constituent alone (Tsai Sc
Dyer, 1973).

The cholic acid will both increase intestinal absorption

and inhibit liver catabolism of cholesterol.

An increased dietary

cholesterol level results in increased chylomicron cholesterol and
liver cholesterol, before finally being reflected in increased LDL,
VLDL, and the appearance of the new species f3 -VLDL and KDL
Umpleby, 1979).

0

(Fears Sc

Unesterified cholesterol is known to exchange be

tween HDD and LDL and the erythrocyte membrane (Bruckdorfer & Graham,
1976); the LDL and HDL are considered as one compartment in the ex
change process (d*Hollander & Chevallier, 1972).

In the exchange

process, LCAT also has a critical role (Glomset, 1970).
There is a specific association of cholesterol with the erythro
cyte membrane band 3 protein by means of a stereospecific niche
(Klappauf Sc Schubert, 1979).

Cholesterol is also known to have a

precise fit among the membrane phospholipids (Huang, 1977), and in
creased erythrocyte membrane cholesterol will decrease the bulk lipid
fluidity (Borochov Sc Shinitzky, 1976).

This increased membrane choles

terol may also alter the conformational changes a transmembrane pro
tein would undergo (Kirby Sc Green, 1980).

Since band 3 is an inte

gral membrane protein, known to transport glucose (Kahlenberg, 1976),
and is intimately associated with cholesterol, the following reasoning
was used.

An elevated dietary cholesterol should elevate the choles

terol content of the plasma lipoproteins; these will exchange with the
erythrocyte membrane.

The increased cholesterol content of the

erythrocyte membrane will alter its structure, inhibit the conforma
tional changes that band 3 requires for transport functioning, decrease
glucose transport, and thereby lower the levels of the glucose metab
olite, 2,3 DBG.
Consequently, the following experiments were designed to quanti
tatively ascertain if:

(1) elevated dietary cholesterol will yield

78

elevated erythrocyte membrane cholesterol and alter its phospholipid
content; (2) there is a concomitant decrease in glucose transport,
as measured by a non-metabolizable glucose analog; and (3) the
lowered intracellular glucose (analog) levels are associated with
lowered 2,3 DPG levels.

METHODS AND MATERIALS
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Two groups of rats were fed commercial rat pellets (control
group) and rat pellets plus cholesterol and cholic acid (experimental
group). A blood sample from either an experimental or control animal
is divided into three aliquots for three separate experiments: 3-0-P^c]
methylglucose (30MG) uptake, 2,3 DPG determination, and a membrane
lipid determination.

For the transport experiments 0.2 ml of packed

erythrocytes were incubated in 1x5, 60, 75, 90, and 105 mg% concentra
tions of 30MG at 37°C.

The uptake was stopped at exactly 30 minutes,
the cells lysed, and the intracellular lli C activity determined by
liquid scintillation counting.

In the 2,3 DPG experiments 0.2 ml of

packed erythrocytes were incubated in h5, 60, 75, 90, and 105> mg% con
centrations of glucose at 37°C.

The incubation was halted at thirty

minutes with perchloric acid, and a frozen protein-free hemolysate was
prepared for subsequent 2,3 PPG determinations.

The membrane lipid

determination began with isopropanol-chloroform extraction of 0.5 1.1 ml of packed erythrocytes.

The extract volume was divided into

a 2 ml aliquot for a cholesterol determination and a 1 ml aliquot for
a membrane phosphorus determination,

The membrane phosphorus is pro-

portional to the total membrane phospholipid,

Both membrane choles-

terol and phosphorus were determined colorimetrically.
Animals, Diets, Blood Collections, and Erythrocyte Wash Solution
Male, Sprague-Dawley rats were used, and housed for 12 months in
As

the Loma Linda University Medical Center - Animal Care Facility,
noted before, hypercholesterolemia can be induced in experimental
animals by administering a diet supplemented with cholesterol,

The

two groups of animals were maintained for ten months on their respec
tive diets as indicated in table 1.
Table 1

Diets for the Control and Experimental Animals

Group

Lab Chow

Control
Experimental

9h.6%
93.3$%

Cholesterol

Cholic Acid

Com Oil

$.b%

1%

0.2$%

$.h%
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Cholic acid feeding enhances cholesterol absorption and inhibits
catabolism of cholesterol to bile acids, thus elevating the liver
cholesterol pool (Beher <k Baker, 1958; Beher et al., 1970).

This
elevated liver cholesterol pool elevates the plasma cholesterol levels.
Cholesterol and cholic acid were dissolved in corn oil to insure
uniform mixing with the ground rat pellets (Purina Laboratory Chow).
All rats received food and water ad libitum.
Blood samples were collected by cardiac puncture under anhydrous
ethyl ether anesthesia using sodium heparin as the anticoagulant, The
maximum blood volume which can be withdrawn from an animal was
determined utilizing the following factors: (a) weight of rat blood =
7.h7% of body weight (Hall et al., 1957); (b) specific gravity of rat
blood = 1.056 g/ml (Creskoff et al., 19U7). The total volume of
blood in a rat = (weight of blood) (l/blood's specific gravity).
Davis et al. (195U) have found that one can withdraw 50% of the total
blood volume, by cardiac puncture under
any deleterious effects. Therefore, no
maximum blood volume was withdrawn from
A Krebs-Ringer-Bicarbonate (K-R-B)

ether anesthesia, without
more than one half of the
each animal.
buffer was prepared according

to the method of Cohen {19h9)'f it was stored at U0C, gassed with CO
2*
monitored for pH stability, and utilized for all erythrocyte washes,
resuspensions, and glucose or 30MG incubation solutions.
3-0A.

[^c]

Methylglucose Uptake
Procedure
A microhematocrit was determined to calculate the blood volume

required to yield approximately 0.2 ml packed cell volume (PCV).

This
blood volume was centrifuged for 5-10 minutes, the "buffy coatn and
plasma removed, the PCV washed twice with K-R-B buffer, the red cells
resuspended in buffer, and a microhematocrit determined. "Hot" 30MG
(lOO^Ci/ml, 6.25 mM) and ‘'cold" 30MG (analytical grade powder) were
combined with an appropriate volume of buffer to ultimately yield 2 ml
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of a solution of the desired concentration (U5

60 mg%, etc.)

after subsequent addition of 0.2 ml of erythrocytes in buffer,

The

initial solution was allowed to reach 37°C in a water bath before
the addition of 0.2 ml of erythrocytes.

The final incubation was

gently shaken for exactly 30 minutes and further penetration of 30MG
was prevented by the addition of 20 ml of ice cold stopping medium
(0.9% NaCl and 2 mM HgCl^) (Barnett et al., 197U; Zeidler et al.,
1976).

The solution was centrifuged at 770 x g (2000 rpm) for eight

minutes in a Beckman refrigerated centrifuge using a Sorvall rotor;
the supernatant was decanted, and the cells washed three times with
K-R-B buffer.

By vortexing with 1 ml of distilled water, the red

cells were lysed; subsequently, 5 ml of 95% ethanol were added to
form a fine precipitate which was mixed and centrifuged for If? min
utes.

Finally, 5 ini of supernatant was decanted into a scintilla

tion vial, 15 ml of scintillation cocktail (New England Nuclear)
were added, and the solution briefly mixed,

The Ik C activity was

counted using a Beckman LS-2f>0 Liquid Scintillation System.
B.

Comments
As a non-metabolizable analog of glucose, 30MG is not phos-

phorylated as it enters the erythrocyte cytoplasm and its levels
can be utilized to determine the extent of transport,

It has been

used to study the kinetics of glucose transport in human (Batt &
Schachter, 1973), rabbit (Regen & Morgan, I96I4.), beef (Hoos et al.,
1972) and rat (Clausen et al., 1973) erythrocytes,

In the facil-

itated diffusion of erythrocytes 30MG has been shown to utilize the
same carrier as glucose (LeFevre, 1961).
For human erythrocytes, glucose turnover or glucose utilization is determined by the activity of hexokinase (HK), the first
irreversible step of glycolysis,

The HK activity is only 10 - 20%

of the Vmax for HK; moreover, the rate of glucose transport through
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the membrane is £0 - 100 x the rate of glucose utilization (LeFevre
& McGinnis, i960). Consequently, the HK enzyme is always saturated
and the transport rate (substrate availability) will not determine
the HK activity and glucose utilization. As was discussed earlier,
the enzyme’s low activity, in spite of substrate saturation, is due
to strong feedback inhibition.
In contrast to human erythrocytes, rat erythrocytes have an HK
activity = 0.17 yumole/min./ml erythrocytes (Christensen et al., 19il9)
which is close to the rate of glucose turnover * O.li; /imole/min./ml
erythrocytes (Heath & Rose, 1969). Therefore the HK enzyme is
operating near its maximum activity. Glucose and 30MG utilize the
same transport system and the rate of 30MG transport = 0.20^01016/
min./ml erythrocytes (Clausen et al., 1973).

Therefore, the trans

port rate of glucose (substrate availability) — hexokinase Vmax —
glucose utilization of the cell.

Hence, if the transport rate

decreases then the lower substrate availability should cause a de
crease in HK activity, and a subsequent decline in erythrocyte glucose
utilization. Incubations were carried out for sufficiently long
periods of time so that a steady state condition is reached with
respect to transport.
A trial determination with old blood (U days old) revealed that
preincubation in glucose did not enable the cells to regain 30MG
transport capability. Consequently, erythrocytes were used within
15 minutes after the blood drawing to minimize any potentially del
eterious effects due to a declining cell viability. The incubation
concentrations were chosen to correspond to the mean blood glucose
values in Sprague-Dawley rats aged 2 - lU.5 months.

This is 75 mg%

with a standard deviation of 8 mg% (Heboid & Bleuel, 1973).
The rate of glucose uptake in human erythrocytes shows two pH
dependent maxima, with the largest occurring at pH = 7.5 and the
smaller at pH = 3.0.

Glucose uptake and substrate concentration

8ii

follow Michaelis-Menten kinetics.

The Vmax, which reflects the

carrier mobility, is pH dependent; therefore, proton binding to the
glucose-carrier complex alters its mobility.

The Km, which reflects

the binding of glucose to the carrier, is pH independent; consequently,
proton binding to the carrier has no impact on the glucose binding
and vice-versa (Lacko et al., 1972).

In view of this, the pH of the

K-R-B buffer was maintained at 7.5 for optimum transport.
The possibility exists that the stopping medium (0.9% NaCl &
2 mM HgCl^) does not act quickly or completely enough and leakage of
the 30M! occurs during the centrifugation and K-R-B buffer washes,
before cell lysis. To ascertain if this occurs, the following ex
periment was performed. A set of uptake determinations, using the
usual procedure and concentrations (hS - 105 nig%), were performed
with an experimental animal; this was defined as the initial CPM
(CPM.). Then a second set of determinations, using the same animal’s
blood, were performed; however, after stopping 30MG uptake the cells
were allowed to remain overnight (at least 12 hours) before the sub
sequent washes and cell lysis. This second set of determinations
was defined as the delayed CPM (CPM^). This sequence was repeated
on a second experimental animal’s blood producing CPM. and CPM^ read
ings for each of the incubation concentrations. Finally, the
difference CPM. - CPM, for each concentration on the two animals was
i

d

calculated and an average (CPM. - CPM^) difference determined. An
analagous series of experiments were run for two control animals.
The results can be seen in table 2. Then the average leakage at a
given concentration was calculated on an hourly basis and this figure
was compared to the average 30MG uptake at the same concentration.
This calculation was expressed as a percent. One can see that, with
one exception, the leakage is <1.2% of the uptake at any given concentration.

Moreover, the time elapsed during the washing was under

85

Table 2

Data and Equations for the 30MG Leakage Test
Experimental

Concentration
mg%

Average Leakage
in CPM ■*

Average Leakage
on an hourly
basis in CPM

U5

9U0

78

60

38

75

U52
10?U

90
105

Comparison
expressed as
a % ***
2.3
0.8
1.2

1032

90
86

1369

HU

0.3

1.2

Control

*

U5

378

32

0.8

60

329

27

O.U

75

799

90

U03

67
36

0.7
O.U

105

273

23

0.1

Average Leakage =

(CPMj - CPMd)l + (CPMj - CPMd)2
2

for two experimental or control animals
Average Leakage on = Average Leakage/12 , the time interval
an hourly basis
between the i and d readings is at least 12 hours
#•**

Comparison expressed _ Average Leakage on hourly basis X 100%,
as a percentage
Average 30M1 uptake
Average 30M1 uptake is the average CPM at a given concentration
for at least four animals.
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one-half hour and consequently the leakage was essentially negligi
ble.
2,3 PPG Determination
The 2,3 DPG measurements were based on reagents and instructions
from Calbiochem of La Jolla, California. Their assay method is based
on that of Nygaard and Rorth (1969). The principle of the assay
system is that enzymatic reactions can be monitored at 3I4O nm if
they are linked either directly or indirectly with an NADH dehydrogenase reaction. NADH absorbs UV light at 3U0 nm, while NAD+ does
not. Therefore, changes in a reaction rate linked to an NADH de
hydrogenase reaction will produce changes in the absorbance at 3h0 nm.
In the erythrocyte, 2,3 DPG is an essential rate determining co-factor
in the 3PG

2,3 PPG
PGM

2PG reaction catalyzed by PGM.

is linked through the 2PG

This reaction

*-PEP and PEP + ADP——^Pyruvate +
rlv
enolase

ATP reactions to the lactate dehydrogenase (LDH) reaction involving
NADH: pyruvate + NADH LDH lactate + NAD. Therefore, changes in the
PGM reaction rate due to changes in the concentration of 2,3 DPG are
reflected in changes of NADH concentration, and its associated
absorbance at 3U0 nm.
Procedure
In a manner analogous to the 30MG procedure, a microhematocrit
was determined to calculate the blood volume required to yield at
least 0.2 ml of packed erythrocytes.

This volume was centrifuged,

the buffy coat and plasma discarded, the PCV washed, the red cells
resuspended in buffer, and a microhematocrit determined. Analytical
grade glucose and an appropriate volume of buffer were combined so
that ultimately, upon addition of 0.2 ml of erythrocytes in buffer,
2 ml of solution with the desired concentration (U5 mg%, 60 mg%, etc.)
would be formed.

Prior to the addition of the erythrocytes, the
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the solution was brought to 37°C in a water bath,

The 0.2 ml of

erythrocytes in buffer were added, the solution was gently shaken,
and was stopped exactly 30 minutes later by the addition of 0.6 M
perchloric acid.

This solution was allowed to stand for 5 minutes
before being centrifuged at 3000 rpm for 5 minutes, One ml of supernatant was diluted with 19 ml of distilled water, This final solution was mixed, was frozen at -20°C, and constituted the protein free
hemolysate. It was stable for extended periods of time ( > 1 week)
and had a dilution of 1:100.
For the 2,3 DPG assay the Calbiochem reagents were reconstituted,
3 ml was pipetted into a dry photometer cuvet, and was brought to
30°C in a constant temperature water bath, The thawed protein free
hemolysates were also brought to 30°C in the water bath, Then 0.1 ml
of the sample was added to the cuvet and quickly, but gently, mixed
by inversion with Parafilm being used to cover the cuvet mouth, The
cuvet was wiped so it was dry and clean of fingerprints and was im
mediately inserted into the 30°C temperature controlled cell of the
photometer. An initial absorbance (Aq) was read exactly two minutes
after the cuvet was placed in the photometer; the final absorbance
(A^) was read exactly four minutes after the initial reading, The
photometer was blanked with double distilled water and all readings
were taken at 3U0 nm. The instrument utilized was a Gilford Photometer Model 222-A with a digital absorbance and concentration meter,
and a Haake Model FE constant temperature circulator.
The 2,3 DPG concentration of a protein free hemolysate with a
1:100 dilution was calculated using the formula:
2,3 DPG concentration in
/u moles/ml erythrocytes

(AA) (N) (^0) (D)
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where:

A A = Ao - A,
N =

®

30°C

2,5 n moles DPG/ml solution

, a conversion factor

AA
The Calbiochem 2,-3 DPG standard solution has a con
centration of 2.5yUmoles DPG/ml solution and was
utilized to determine the conversion factor, N, as
follows. One volume of this standard solution was
diluted with 99 volumes of distilled water to pro
duce the 2.5 nanomoles DPG/ml solution. Therefore,
this latter solution has a concentration of 2,3 DPG
which would be found in a 1:100 dilution of whole
blood or hemolysate containing 2.5/imoles DPG/ml.
PCV = packed cell volume
D 3 a dilution factor utilized if the reaction was
too rapid or slow and .the sample required
diluting or concentrating.
Membrane Lipid Determination
A.

Lipid Extraction'
The lipid extraction procedure of Folch, Lees, and Stanley-Sloane

(1957) using methanol-chloroform 1:2 (v/v) is applicable for many
tissues, but is not useful for the extraction of erythrocyte lipids.
Rose and Oklander (1965) have found that heme pigments are extracted
with methanol and these give rise to high values of cholesterol in
the extract, when measured by the FeCl^-H^SO^ method of Zlatkis, Zak,
and Boyle (1953).

Consequently Rose and Oklander use isopropanol-

chloroform 11:7 (v/v) combination of solvents; the isopropanol ex
tracts little pigment and gives quantitative extraction of cholesterol
and phospholipids.
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Procedure
The blood was prepared in a manner analogous to that in the
2,3 DPG and 30MG uptake determinations. A microhematocrit was run to
determine the blood volume required for lipid extraction, Next, this
1.

volume was centrifuged, the supernatant discarded, the PCV washed
with buffer, the erythrocytes resuspended in buffer, and a second
microhematocrit determined.
To a calculated PCV of erythrocytes in a 20 ml test tube, 1 ml
of distilled water was added and the cells were lysed by vortexing.
Then the mixture was allowed to stand for l£ minutes. as 11 ml of
isopropanol was slowly added, and the mixture gently stirred, the red
cells turned dark brown and clumped, Maximum access of the extracting
solvent to the cells was desired, so clumping was retarded as long as
possible by the slow addition, One hour later 7 ml of chloroform
were added and mixed; this produced a rubber-like mass. At the end
of a second hour, the solution was centrifuged at iiOOO rpm for ten
minutes at 10°C. The supernatant volume of 19 ml was transferred to
a test tube and stoppered; filtration of the supernatant was performed
if it was contaminated by flecks of clumped cells, Any re-extraction
of the pellet was performed using the initial isopropanol-chloroform
volumes of 5.5 ml and 3.5 ml respectively. The re-extraction used the
same volumes of solvent, so that the final supernatant volume was
19 ml.
Evaporation of the Lipid Extract
2.
A 2 ml aliquot of the lipid extract was transferred volumetrically
to a conical glass stoppered centrifuge tube. The solution was evaporated almost to dryness, but no further; this prevented lipid oxidation. A boiling water bath was used and an air stream kept the
supernatant surface tension down to prevent "popping” of the tube’s
contents.

Once the solvent had evaporated, the stoppered tube was

allowed to cool and 2 ml of ethanol were added in preparation for the
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cholesterol determination.

Again, ethanol evaporation was prevented

by stoppering the tube.
B.

Cholesterol Determination
The method of Zlatkis, Zak, and Boyle (1953) was modified by

Wolf and Bauman (1970) so that ethanol replaced glacial acetic acid.
1.

Procedure
To the 2 ml of lipid extract supernatant, which were now dissol

ved in ethanol, 2 ml of color reagent were added (reagent concentra
tions will be discussed below). This addition was made down the side
of the centrifuge tube so that a layer forms underneath the ethanol.
After stoppering the centrifuge tube and vortexing gently to mix the
contents, it was allowed to stand for 30 minutes to produce the color
reaction.

An appropriate volume was transferred to a Spectronic 20
cuvet which was clean and free of scratches or fingerprints. The
Spectronic 20 spectrophotometer was blanked with a solution of 2 ml
of ethanol and 2 ml of the color reagent.

The absorbances of all

samples were read at 550 m//. and thirty minutes after the addition of
the color reagent. The solution's concentration was read from a
standard curve described below.
Reagents, Standard Curve, and Comments
2.
The iron stock reagent was prepared by dissolving 2.5 grams of
ferric chloride (FeCl^^H^O) in 100 ml of 87% phosphoric acid (H^PO^).
This reagent was stable indefinitely.

The color reagent was prepared

by diluting 8 ml of the iron stock reagent to 100 ml using concentrated
sulphuric acid.

This Zak reagent was used before 6 to 8 weeks, be

cause a precipitate will form by then.
The standard curve reagents consisted of a cholesterol stock
standard and cholesterol working standards.

The stock standard was

prepared by dissolving 100 grams of analytical grade cholesterol in
100 ml of absolute ethanol.

Various volumes of the stock standard

91

were diluted with ethanol to produce working standards of 25 nil each,
whose concentration varied from 0 to 3.0 mg in 0.25 mg increments.
The cholesterol concentration range was determined by using the value
of rat erythrocyte membrane cholesterol = 1.32 mg/ml packed red cells
as a guide (Nelson, 196?).

The standard curve (absorbance vs choles

terol concentration) was prepared by treating 2 ml of the working
standards as 2 ml lipid extracts in ethanol.

Three determinations

were made for each point of the curve.
C.

Phosphorus Determination and Phospholipid Calculation
Prior to performing a membrane lipid phosphorus determination,

the lipid extract was washed to remove the inorganic phosphorus.

The

washing method used was that described by Folch et al. (1957).
1.

Washing the Lipid Extract
Procedure:
Volumetrically, a 1 ml aliquot of the lipid extract was trans

ferred into a round bottom flask.

Using a rotary evaporator setup

(water bath temperature was 82°C, the higher boiling point of the two
solvents), the solution was evaporated just to dryness; the afore
mentioned caveat of the lipid extraction procedure was observed.
Chloroform-methanol 2:1 (v/v) was added to wash down the sides of the
flask after it had cooled below 6l°C (boiling point of chloroform 3
6l°C; boiling point of methanol = 65°C).

This constituted the crude

extract of Folch et al. (1957) which was then transferred to a glass
stoppered centrifuge tube,

To this was added a volume of 0.05 N KC1

which equaled two-tenths of the volume of the crude extract.

This

salt solution and the crude extract were mixed by vortexing, taking
care not to leave any solution on the stopper,

After allowing the

centrifuge tube to stand overnight, the mixture separated into two
phases, upper and lower, which constituted b0% and 60% of the total
volume respectively.

The pure solvents of the upper phase were

chloroform-methanol-salt solution, 3 : U8 : !t7; the pure solvents
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of the lower phase were chloroform-methanol-salt solution, 86 : lU : 1.
If a stirring rod was utilized in the initial mixing instead of vortexing, it was washed with a minimum amount of pure solvents lower
phase.

The upper phase was removed with a Pasteur pipette taking

care not to disturb the interface between the phases.

This removal

of the upper phase solvents was completed by rinsing the centrifuge
tube walls and the interface with 1.5 ml of pure solvent upper phase.
This rinse operation was performed so that mixing of the two phases
does not occur.
Comments:
Phosphate from the detergents used for cleaning glassware tended
to remain and would have distorted the phosphorus determination.

To

prevent this, all glassware so washed was subsequently washed again
with 70% sulphuric acid, and triple rinsed with distilled water.
2.

Lipid Phosphorus Determination
The method utilized was a modification of Bartlett's (1959) for

total phosphorus analysis of elutates from chromatographic columns.
Procedure:
A 2 ml sample of the lower phase of the lipid extract wash was
evaporated in a conical centrifuge tube by means of a water bath.
was blown across the surface to prevent popping.

Air

Then 1 ml of dis

tilled water and 0.5 ml of 10 N H^SO^ were added, mixed by vortexing,
and placed in an oven at 155°C for 3 hours.

The strong acid and heat

digested the organic material to produce carbon.

Next, the centrifuge

tube was cooled slightly, had two drops of 30% H^O^ added, and was
returned to the oven for 1^ hours.

This procedure oxidized the carbon

to CO^ and water and the solution cleared.

After being cooled to room

temperature U.6 ml of 0.22% ammonium molybdate solution were added
and the solution was mixed by vortexing.

Then 0.2 ml of the NNS

reagent (composition described below) were added and mixed.

This

final solution was placed in a boiling water bath for ten minutes with
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a marble in the opening of the centrifuge tube; as the solution
cooled to room temperature, a blue color appeared. After being diluted to 5 ml with distilled water, the solution’s absorbance was
read at 830 mfx, The Spectronic 20 spectrophotometer was used with
a red sensitive phototube and filter; the blank was treated by the
same procedure just described, The concentration in ym g phosphorus/
ml was read from the standard curve using the sample absorbance.
Reagents and Standard Curve:
The NNS reagent was prepared fresh just prior to use. A stop
pered, graduated cylinder with IiO ml of water had 6 grams of sodium
bisulfite added and the contents were dissolved by shaking. Then
0.1 grams of l-amino-2-naphthol-U-sulfonic acid were added and the
solution was vigorously shaken. Finally, 1 gram of sodium sulfite
was added, the solution was shaken for five minutes, and the contents
were filtered into a brown bottle.
A phosphorus stock solution was prepared by dissolving 0.2397
grams of KH^PO^ in distilled water and by diluting the solution to
25>0 ml in a volumetric flask; this produced a solution of 0.5 mg/ml.
Appropriate volumes of the stock solution were diluted with distilled
water to yield working solutions whose concentration varied from
0 to 10 fig/ml in 1 /4g increments. Two ml of each working solution
were treated as a lipid extract wash and the absorbances were deter
mined to plot a standard curve.

Each point of the curve represents

two closely agreeing determinations.
Membrane Phospholipid Calculation
Since each phospholipid contains one atom of phosphorus, there
is a direct proportion between the amount of phosphorus measured
colorimetrically and the amount of phospholipid which gave rise to it.
3.

According to Nelson (196?), Sprague-Dawley rat erythrocytes have a
total lipid content of 5*08 mg/ml packed cells.

Phospholipids con-

9h

stitute 6?% of the total lipids or 3.U0 mg/ml packed cells, and
from my data the average membrane phosphorus value = .3I4.O mg/ml
packed cells.

Consequently, the proportionality constant is 10.

RESULTS AND DISCUSSION
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Membrane Cholesterol, Phospholipid, and Cholesterol/PL Ratio
A.

Cholesterol
For the experimental group of animals (6) there was a rise in the

mean membrane cholesterol levels as compared to the control group (same
number of animals) (p<0.01); the mean for the experimental group = 2.21
mg/ml packed cells, and the mean for the control group = 1.1*7 mg/ml
packed cells (see figure 1).

The membrane cholesterol value for the

control group agrees with that of other investigators.

For Sprague-

Dawley rat erythrocytes. Nelson (196?) determined the membrane choles
terol to be 2h»7% of the total neutral lipid or 1.25 mg/ml packed
cells.

Bjomson et al., (1975)> also using Sprague-Dawley rats, de

termined a value of 1.70 mg/ml packed cells. The percentage increase
in the membrane cholesterol was 50.3% on a diet which was 1% choles
terol, 0.25% cholic acid, and 9.6% fat (U.2% from the laboratory chow
and 5.U% from the corn oil); all percentages are by weight. In agree
ment with this finding is the work of Pelliniemi et al. (1976) who
noted a 35% increase in membrane cholesterol in two weeks and a 1*1*%
increase in three weeks. These investigators used Sprague-Dawley rats
and a diet with 1.5% cholesterol, 0.5% sodium cholate, and 20% fat
(all percentages are by weight); the fat was neutal with respect to
changing serum cholesterol levels.
B.

Phospholipid

The control group of animals has a mean value for the membrane
phospholipid of 3.U0 mg/ml packed cells. This is in very close agree
ment with the value determined by Watson (1963) of 3.39 mg/ml packed
cells. In comparison with the mean of the control group, there is
a decrease in the mean membrane phospholipid content of the experimental group (p<0.05); the experimental group has a mean of 2.15
mg/ml packed cells (see figure 1). The percentage decrease in the
membrane phospholipid in the experimental group is 36.8%.
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Fig. 1 Mean erythrocyte membrane cholesterol and phospholipid
content in mg/ml packed cells with confidence intervals;
membrane cholesterol/phospholipid ratio in mg/mg with
confidence interval. Control group (C), Experimental group (E)
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C.

Cholesterol/Phospholipid Ratio (C/PL)
The mean C/PL ratio for the control group of animals is O.U; (mg/

mg). Nelson (196?) has determined a C/PL ratio of 0.37 and Pelliniemi
et al. (1976) a value of 0.5>0j both investigators used Sprague-Dawley
rats.

Jain and Subrahamanyan (1976) had a very similar value of 0.U3.

There is a dramatic increase in the experimental group’s mean C/PL
ratio to 1.10 (mg/mg), and this increase is statistically significant
(p<0.01) when compared to the control group's mean.

An increase in

the C/PL ratio of 1^1% reflects both the 5>0.3% increase in membrane
cholesterol and the 36.8% decrease in membrane phospholipid.
Additional Discussion
D.
Because the erythrocyte lacks de novo synthetic pathways for cho
lesterol and phospholipids, the plasma milieu determines the lipid
composition of the red cell membrane. The changes in membrane choles
terol and phospholipid which occurred with the diet used in this report
are parallel to the plasma changes in cholesterol and phospholipid
which Mahley and Holcombe (1977) noted, when rats were fed a similar
diet (1% cholesterol, 0.3% taurocholic acid, and 5% lard). They noted
a 25.5 to 29.3% increase in the total plasma cholesterol and a 10.7%
decrease in the total plasma phospholipid. These changes parallel the
50.3% increase in membrane cholesterol and 36.8% decrease in membrane
phospholipid noted above.
Mahley and Holcombe also noted an alteration in the type of lipo
proteins and the distribution of cholesterol, PL, and protein among
the lipoprotein classes.

There was an increase in the density < 1.006

lipoproteins (VLDL and f3 -VLDL), an increase in LDL, the appearance of
HDLc, a decrease in the amount of typical HDL, and increased amounts
of an arginine-rich apoprotein. In the control animals the typical
HDL (density = 1.08 - 1.21) contained 5b% of the total plasma choles
terol, and h9% of the total plasma PL.

In the cholesterol fed animals,

most of the plasma cholesterol and PL were now found in the elevated
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levels of VLDL and the new /B -VLDL; specifically, 5U.2 - 8U.6% of the
cholesterol and U7.Ii - 82.6% of the PL were located in these fractions.
The percentage of cholesterol and PL in the LDL fraction also increas
ed, and the newly appearing HDLc (density = 1.006 - 1.08) also had high
percentages of cholesterol and PL.

As was discussed in the literature

review, other investigators using cholesterol rich diets have noted
similar increases in the amount of cholesterol and its redistribution
among the lipoprotein classes^ moreover, they also found new lipoproand [3 -VLDL.
c
'
The cholesterol in the LDL and HDL

tein classes — HDL

fractions is largely esteric
fied (approximately 75%) (Mahley & Holcombe, 1977). In contrast, VLDL
and /3 -VLDL, newly synthesized in the liver and incorporating free
cholesterol from the hepatic pool, probably have a much lower percen
tage of esterified cholesterol.

The ratio of unesterified cholesterol

to esterified cholesterol is approximately 1:1 for human VLDL (Bhagavan,
1978).
It is known that only unesterified cholesterol exchanges with the
erythrocyte membrane (Bruckdorfer & Graham, 1976).

Cooper et al.

(1975) have shown that the unesterified cholesterol/PL ratio of the
erythrocyte milieu determines the cholesterol content of its membrane.
Secondly, the unesterified cholesterol exchange occurs from a lipo
protein or liposome with a high unesterified C/PL ratio to a red cell
whose unesterified C/PL ratio is lower (Cooper et al., 1975; Cooper,
1978).

The VLDL and /3 -VLDL in Mahley and Holcombe’s work, contain

ing exchangeable unesterified cholesterol, had C/PL ratios of l.i|2 to
1.72.

The erythrocyte C/PL ratio in this report was 0.1^ for the con

trol group and 1.10 for the experimental group.
Therefore, based on the similarity of the diet in this study to
Mahley and Holcombe's diet, the plasma here probably contained VLDL
and f3 -VLDL with exchangeable cholesterol,

The C/PL ratios in these

lipoproteins would be sufficiently large (1.U2 to 1.72 compared to the

100

control erythrocyte’s C/PL = 0.14*; this 0.14* value would be approxi
mately equal to the experimental erythrocyte’s initial C/PL ratio)
to produce the C/PL ratio of 1.10 in the experimental group,

More-

over, there is a decreased amount of typical HDL which normally re
moves the erythrocyte free cholesterol by the scheme of Glomset (1970).
In this process, the LCAT esterifies the surface cholesterol of the
HDL, the esterified cholesterol passes into the core of the HDL, and
the HDL surface picks up free cholesterol upon collision with the
erythrocyte. Finally, in diseases with low LCAT activity (liver
disease and LCAT deficiency), the plasma C/PL ratio increases, red
cell cholesterol increases, and target cells appear, Hence, LCAT activity is necessary for the removal of erythrocyte membrane choles
terol.
In summary, a high cholesterol diet could elevate erythrocyte
membrane cholesterol by:

(1) increasing the density < 1.006 lipo

proteins (VLDL & [3 -VLDL) which have exchangeable unesterified cho
lesterol; (2) increasing the unesterified C/PL ratio in those lipopro
teins with the exchangeable cholesterol; and (3) decreasing the sub
strate which LCAT requires for the removal of the red cell’s choles
terol, i.e., the typical HDL. It should be pointed out that the
situation is probably much more complicated, since HDL metabolism is
still not understood and several subfractions have been found.

For

example, HDL^ is an inhibitor of LCAT and HDL^ is its substrate,
although HDL and VLDL have usually been recognized as the substrates
(Pinon et al • i 1980). These two subfractions have also been identified
in the rat (Rubenstein & Rubenstein, 1973).
The liver-synthesized VLDL is transformed via an intermediate
density lipoprotein to LDL.

During this process, PL and cholesterol

are freely exchanged with the HDL and the resulting LDL is high in
cholesterol esters.

Presumably, on the high cholesterol diet with el

evated levels of VLDL, this also occurs, and produces increased
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quantities of IDL and maybe HDL .

However, with the appearance of

more VLDL and the new species /3 -VLDL, this transformation process
may be ’’swamped" and the plasma level of free cholesterol rises.
Whether either of these species exchanges cholesterol with the erythro
cyte is unknown, but as the previous discussion indicates, they may
have the potential based on their cholesterol/PL ratio and unesterified
exchangeable cholesterol.
Evidence which supports the concept that other lipoprotein species
may be responsible for increasing the erythrocyte membrane cholesterol,
also illustrates a mechanism for the exchange process.
found in the study of lipoprotein X (LP-X).

This has been

In LCAT deficiency and

different liver diseases (especially obstructive jaundice) the red
cells accumulate cholesterol and have the abnormal lipoprotein, LP-X.
It has an electrophoretic mobility of the LDL, an unesterified choles
terol/lecithin ratio = 1, lacks apo A-I for LCAT activation, and has
been shown to fuse with the erythrocyte membrane (Bhagavan, 1978; Van
Deenen et al., 1976).

Verkleij et al. (1976) have demonstrated, using

freeze-etch electron microscopy, that this is a two stage process.
The initial stage (within two minutes) produces smooth areas in the
membrane fracture faces, but normal distribution of the intramembranous
protein particles.
cles at this stage.

The sections show the adhesion of the LP-X parti
In an end stage (occurs at 2 hours) the LP-X

vessicles are no longer present, supporting the idea that fusion of
the vessicles with the membrane follows adhesion.

There is also a de

crease in particle density at this stage.
The erythrocyte phospholipids are in equilibrium with the plasma,
but the exchange rate for SM is very slow and the plasma levels of PE
and PS are very low.

Consequently, in considering PL exchange, the

most rapidly turning over specie and the one present in largest amounts
is considered.

Phosphatidyl choline (PC) can exchange with the erythro

cyte membrane in two ways:

(a) directly as an intact molecule (rate
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slower than that for cholesterol) and (b) indirectly as lyso PC.

The

lyso PC is produced in the plasma by LCAT, bound to albumin, and exchanges in this latter form. Once in the membrane, lyso PC can under
go three reactions, the most important being reacylation with a free
fatty acid to produce PC (Shohet, 1972).
The lower levels of PL in the experimental group could occur in
the following manner. First, the turnover of PC in the membrane would
gradually lower the PC levels as the intact molecules left, The re
plenishment of these molecules would be decreased due to either lower
ed plasma PL levels, or a "tighter" membrane which occurs with an increased cholesterol content. As was noted in the literature review,
the partitioning of molecules into the membrane may be inhibited by
increasing its cholesterol content. Secondly, this inhibition of
partitioning may also affect the entry of lyso PC from albumin, Therefore, the membrane's PC content would gradually decline, while replen
ishment would be impeded by one or more of the mechanisms described.
As stated above, PC is the most exchangeable of the four major
erythrocyte membrane PL, and it constitutes 28.8% of the total PL in
human erythrocyte membranes, However, it comprises U7.5% of the PL in
the rat red cell (Bruckdorfer & Graham, 1976). Consequently, the de
cline in PL for the rat's erythrocyte membrane might possibly be
greater than for humans. This may imply that the human erythrocyte's
total phospholipid content is more stable toward dietary alteration
due to a lower percentage of readily exchangeable PC.
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Methylglucose Transport

N

Figure 2 illustrates the difference in the uptake of 3-0methylglucose for the experimental and control animals' erythrocytes,
for varying 30MG incubation concentrations.

The cpm is proportional

to the intracellular concentration of "hot" 30MG.

Since the propor

tion of "hot" to "cold" 30MG was kept constant in each incubation solu
tion, the cpm is also proportion to the total ("hot" + "cold") intra
cellular 30MG concentration.

When the extracellular 30MG concentration

is
60, 75, and 90 mg%, then the intracellular 30MG is less for the
experimental group in comparison to the control group; the confidence
intervals are indicated in figure 2. Sprague-Dawley rats have a blood
glucose value whose mean ± standard deviation equals 75-8 mg% (Heboid
& Bleuel, 1973).

This range of blood glucose values overlaps the

range of incubation concentrations for which there is a difference be
tween the experimental and control groups for 30MG uptake (p values in
table 1). Since 30MG and glucose utilize the same membrane carrier,
one concludes that the curves are probably meaningful, for in vitro
glucose transport, for the concentrations of approximately 60 to 85 mg%.
The percentage decrease in the mean 30MG uptake for the experimental
animals, as compared with the control animals, is 32.8% and 26.3% at
the incubation concentrations of 60 mg% and 75 mg% respectively.
A computer program for the Student t Test was utilized, Each
point on the control or experimental curve represents the mean value
from at least four animals, except the + determinations (see table 1)
where three animals were used. All data points on a particular curve
utilize blood from the same four or five animals, Normally, statistical analysis of the data would not use multiple t tests, Ideally, one
would use more animals to determine each point on a curve, and differ
ent animals for each point (to provide independence of points), so
that an analysis of variance (ANOVA) could be performed.

3
Fig. 2 (opposite page) cpm x 10/0.2 ml packed cells versus 30MG
concentration in mg% for the control and experimental groups.
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Table 1

Data and p Values for the 30MG Transport Determination

30MG Incubation
Concentration in
mg%

*

Mean
cpm x 10-yQ.2 ml packed cells
Control
Experimental

p values

us

t UlU3

3,U57

P>0.25

60

7226

M58

p < 0.10

75

10, 2l*2

7,553

p< 0.25

90

9,257

t 7,313

P>0.25

105

18,907

3U,U19

p<0.25

p values for the difference between the experimental and control
group means, as measured in cpm x 10^ for 0.2 ml packed cells,
see text.
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These results provide some useful exploratory findings for the
following reasons:

(l) the main effect which is most interesting is

the effect of cholesterol on the 30MG transport; the other main
effect, how the incubation concentration affects 30MG transport, is of
secondary interest; (2) the difference in 30MG transport for the two
groups at incubation concentrations similar to blood glucose values
(60 and 75 mg%) have the best p values; and (3) the interaction
effect, the combined effect of cholesterol and incubation concentra
tion on the dependent variable, is probably nonexistent for the physio
logically important incubation concentrations, since the two curves
are parallel for the concentrations 60 to 90 mg%.
There are two major mechanisms whereby cholesterol might inhibit
band 3 functioning, and decrease 30MG or glucose transport.

Either

or both could conceivably be operating.
First, the excess membrane cholesterol either directly or in
directly inhibits the conformational changes that band 3 requires for
30MG transport; i.e., alters the carrier's Vmax. This could occur
directly because of the close and specific association of cholesterol
with band 3 (Klappauf & Schubert, 1979). Cholesterol could indirectly
affect the band 3 - Pb interaction by its ability to change the bulk
membrane fluidity via an altered fatty acyl chain mobility which may
particularly affect the boundary PL.
The second major mechanism for inhibiting band 3's transport
capability would be to decrease its affinity for 30MG or glucose, i.e.,
change the carrier's Km.

As noted before, Masiak and LeFevre (197U)

found for an increase in human erythrocyte membrane cholesterol that
(2:3, cholesterol:lecithin as compared to the control erythrocytes'
proportion of 1:3) there is a four-fold increase in the Km for
glucose, i.e., a decrease in the carrier's affinity for glucose.

They
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attributed this decrease in affinity to steric hindrance or an altered
accessibility of the carrier to the substrate.
How might the membrane1s cholesterol content alter the accessibil
ity of band 3 to 3011} or glucose?

As was discussed in the literature

review, band 3 is bound to the underlying cytoskeleton in two ways.
A small percentage (l£%) is bound to spectrin via ankyrin, but the
majority is immobilized by an ionic strength and temperature dependent
entanglement of the molecule^ cytoplasmic portion in the spectrinactin meshwork (Golan and Veatch, 1980).

These investigators proposed

that there is a relatively loose, but metastable state for the

cyto

skeleton which is intermediate between tight binding to the membrane
and complete dissociation from it. This latter state would allow rapid
lateral diffusion of band 3. It is also known that the band 3 protein
kinase is located on the cytoplasmic portion of the molecule and the
activity of this enzyme and spectrin kinase are both sensitive to
membrane cholesterol levels (Vickers & Rathbone, 1979)* Phosphoryla
tion determines the spectrin-actin interactions and glycoprotein
lateral mobility through the intracellular ATP levels (Fairbanks et
al., 1978).

Glycophorin A dimers are also closely associated with

spectrin as Nicolson and Painter (1973) have shown. They found that
incubation of red cell membranes with antispectrin antibodies shifted
the distribution of glycophorin molecules on the cell surface. More
over, glycophorin A and band 3 have been shown to exist as a complex
in the membrane and are believed to be responsible for the intramembranous particles seen in freeze-fracture electron microscopy of
the erythrocyte membrane (Nigg et al., 1980). Therefore, apparently
the band 3 - glycophorin A complexes have their cytoplasmic portions
protruding into the interstices of the spectrin-actin network (see
figure 1 in the literature review). This limits the long range lat
eral diffusion of the complexes, presumably by the aforementioned
entanglemento

Hence, if the metastable state of the cytoskeleton is
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disturbed, then one might expect the constraints on band 3 - glycophorin A complexes to be removed and particle aggregation to occur.
Evidence supporting this comes from Elgsaeter et al. (1976) who found
++

that the same conditions (pH = U.8, plus low Ca+ , Mg , polylysine
or basic protein concentrations) which precipitate spectrin-actin
mixtures, will also cause intramembranous particle aggregation in
spectrin depleted ghosts. In addition, Grazlitt et al. (1977) have
shown that rat erythrocytes treated with lidocaine, tetracaine, and
chlorpromazine exhibit rapid (10 minutes) ATP depletion and aggregation of intramembranous particles. It is believed that the dephos
phorylation of membrane proteins by anesthetic drugs and chlorproma
zine may be due to activation of a phosphatase or alteration of the
lipid-protein associations so that phosphate bonds in proteins are
exposed to phosphatase activity.
The role of lipoproteins (LDL) in modulating the functioning of
the cytoskeleton and the cell's morphology by activation of phospha
tases, has already been discussed (see the first section in the lit
erature review on erythrocyte membrane - structure and function).
Hui and Harmony (1980) had determined that upon incubation with LDL,
the human erythrocyte morphological changes observed were due to an
increased activity of the membrane-bound phosphatases, They found no
change in the intracellular glucose. Pi, or ATP concentrations, the
protein kinase activity, or the membrane lipid composition. Since
LDL do not enter the erythrocyte, but bind to the cell surface quite
readily (10^ bind the red cell in 10 - l£ minutes @ 37°C), and in
view of the above factors which do not change, these investigators
suggested that LDL may enhance phosphatase activity by a perturbation
of the intracellular ion concentrations.

They determined Na+ was not

affected and are currently investigating Ca

++

and K+.

The calcium

ion is certainly a good candidate (see literature review), since Ca++

no

initiates transainidative cross-link formation.

Their incubation time

was only four hours, so although they found no change in membrane cho
lesterol or PL content, longer incubation times certainly would have
shown elevated membrane cholesterol levels, as has been previously
demonstrated (Cooper et al., 1975; Cooper, 1978). The work of
Verkleij et al. (1976) concerning LP-X fusion with erythrocytes (see
previous section) indicated that at the later stage (after two hours),
the intramembranous particles in the fracture faces had aggragated
and the cell had enlarged.
Synthesizing the foregoing findings, a mechanism can be postula
ted for how cholesterol laden lipoproteins might alter band 3's acces
sibility to glucose.

The lipoprotein itself readily adheres to the

erythrocyte in a short time (few minutes) and alters the intracellular
ionic environment to activate the membrane-bound phosphatases.

These

perturb the spectrin-actin interaction, so that the cell morphology
changes. The cytoskeleton is still associated with the membrane, and
particle aggregation is constrained. This process would correspond
to the initial stage of Verkleij et al. (1976) and Hui and Harmonyfs
(i960) short incubation time. For extended incubation periods (e.g.
> 6 hours in Cooper et al., 1975* and up to months in disease states
or dietary habits), the repeated binding of lipoproteins increases the
membrane^ cholesterol content. This alters the cytoskeleton-membrane
association so that either the cytoskeleton dissociates from the mem
brane completely and/or the particle entanglement in the cytoskeleton
is relieved.

Without the constraint of the spectrin-actin network,

the band 3 - glycophorin A complexes aggregate.

Consequently, with

band 3 now clustered on the erythrocyte^ surface, it would be less
likely to encounter a 30Mj or glucose molecule than if it were uniform
ly dispersed.

Alternatively, the membrane cholesterol content might

alter the extracellular portion of band 3 and inhibit 30M} or glucose
binding.
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Intracellular 2,3 PPG Concentrations
Figure 3 illustrates the difference in 2,3 DPG production between
the experimental and control animals’ erythrocytes, for varying glu
cose concentrations.

Each point on a particular curve represents the

mean of at least four animals and all data points on the same curve
utilize blood from the same four or five animals.

The comments in the

prior section regarding multiple t tests and ANOVA are also applicable
here. The control group’s 2,3 E)PG concentrations are similar to those
of other investigators using Sprague-Dawley rats, e.g., 8.U Mmoles/ml
erythrocytes (Woodson et al., 1973).

At glucose incubation concentra

tions of U5, 60, and 75 nig % the experimental group’s mean 2,3 PPG
concentrations are less than those of the control group (p values in
table 2).

The confidence intervals are shown on the graph of figure 3.

For the same glucose concentrations mentioned above, the percentage
decreases in the experimental group’s mean 2,3 DPG concentrations, as
compared to the control group’s mean concentrations, are 11.5%* 9.9%,
and 10.1;% respectively. As previously mentioned, Sprague-Dawley rats
have a blood glucose concentration of 75 - 8 mg
this concentration
range overlaps the incubation concentrations for which there is a dif
ference between the mean 2,3 DPG concentrations in the experimental
and control groups. Consequently, the in vitro glucose transport
and the subsequent 2,3 DPG production for the experimental and con
trol animals may reflect the in vivo situation.
The lowered 2,3 DPG levels in the experimental animals could be
caused by two primary factors — altered substrate (glucose) availa
bility or a pertubation in the activity of glycolytic and 2,3 DPG
synthetic and degredative enzymes.
First, the glycolytic rate is the major factor in controlling
1,3 DPG levels which determine, in part, the DPG synthase activity.
This is true because physiologic levels of 1,3 DPG are insufficient
to saturate the enzyme.

Therefore, the glycolytic rate is the primary

Fig. 3 (opposite page) 2,3 DPG concentration in >amoles/ml
erythrocytes versus glucose concentration in mg% for the control
and experimental groups.
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Table 2

Data and p Values for the Intracellular 2,3 DPG Determination

Glucose Incubation
Concentrations in
mg%

*

Mean 2,3 DPG Concentrations
in
M moles/ml erythrocytes
Experimental
Control

p values
*

h5

8.5o

7.52

p< 0.10

60

8.89

8.01

p< 0.25

75

8.95

8.02

p< 0.25

90

7.62

7.7U

p > 0.25

105

7.32

7.66

p> 0.25

p values for the difference between the experimental and control
group mean 2,3 DPG concentrations.
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factor in determining 1,3 E)PG levels and subsequently 2,3 DPG levels.
As was noted in methods and materials, for rat erythrocytes the 30MG
transport rate (substrate availability) is approximately equal to the
Vmax for hexokinase (HK), which is also fairly close to the cell’s
glucose turnover rate. Consequently, impaired transport would be
expected to lower the HK activity (a key glycolytic control point),
the glycolytic rate, and subsequently 1,3 DPG and 2,3 DPG levels.
How cholesterol might perturb glycolytic and synthetic or degredative enzymes controlling 2,3 DPG levels is purely speculative.
However, of the three key glycolytic control enzymes —HK, PFK, and
PK—the PFK enzyme is quite sensitive to pH, is bound to the membrane
and band 3, and is known to be a primary control enzyme for regulating
intracellular ATP levels. The association-dissociation of PFK, as
well as other glycolytic enzymes (aldolase and G3PD) to or from the
membrane, may regulate the catalytic efficiency of glycolysis (see
the literature review section on band 3 associations).

Consequently,

membrane cholesterol accumulation may inhibit the partitioning of this
key control enzyme onto the membrane and thereby decrease the effi
ciency of glycolysis.

As mentioned earlier, membrane cholesterol may
alter the intracellular ionic conditions which would change enzyme
activity, perturb the kinetics of enzyme association-dissociation
with the membrane (association is reversed by increased ionic strength),
and subsequently alter ATP levels.

Since 2,3 DPG and ATP levels are

apparently regulated together, then a cell with less glucose available
due to inhibited transport and/or impaired enzyme activity, might
shunt less substrate into 2,3 DPG synthesis and more into critical
ATP production.
Cholesterol may regulate intracellular pH by the following scheme.
For cold-stored blood, the decrease in intracellular pH is due to
lactate production.

This declining pH inhibits glycolysis and 2,3 DPG

synthesis as well as accelerating the destruction of 2,3 DPG by DPG
phosphatase (DPGP).

The DPGP activity is increased under acid
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conditions. Normally lactate freely diffuses through the membrane,
but the additional cholesterol may impede this process, producing
the lowered intracellular pH and subsequent decline in 2,3 NPG levels.
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Corrroarative Results and Discussion
Considering the 30MG transport and 2,3 DPG graphs, one notes that:
(1) at the 60 mg% and 75 mg% incubation concentrations on both curves,
the experimental group has lower values when compared to the control
group (p < 0.25)j (2) the peak value for the intracellular 30MG and
2,3 DPG concentrations occurs at 75
for both the experimental and
control animals; (3) at the 60 mg% and 75 mg% incubation concentrations,
there is approximately a 30% decrease (32.8% and 26.3% respectively)
in the experimental group's mean 30MG transport as compared to the con
trol group's mean value; and (U) at those same incubation concentra
tions the experimental group's mean 2,3 DPG values are approximately
10% (9.9% and 10.U% respectively) less than the control values. Appar
ently at 30MG incubation concentrations > 90 mg% the facilitated dif
fusion transport mechanism is overridden, but the 2,3 DPG values re
main low despite the high intracellular 30MG (glucose) values.

The ex

perimental 30MG uptake curve is above the control curve at incubation
concentrations of 105 mg% (p < 0.25). At the same incubation concen
tration, the difference between the experimental and control mean
2,3 DPG concentrations is not statistically significant (p > 0.25).
A Pearson correlation coefficient (r) was calculated, using a
computer program, for 2,3 DPG and glucose concentrations, for cpm
(which is proportional to intracellular 30MG concentrations) and extra
cellular 30MG concentrations, and for cpm and 2,3 DPG concentrations.
The underlying assumption of linearity for the Pearson r was recognized
for the incubation concentrations (1|5 nig%, 60 mg%, and 75 mg%) utilized
in the calculation. Because the points on a particular curve are not
independent, and correlation analysis assumes independence of points,
the possibility exists that the dependence of the points controls the
linearity.

Table 3 shows the results.

The regression equation was

also determined and the slopes (B) of the corresponding equations are
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also indicated in table 3.
One notices a very high degree of association between 2,3 DPG
and the extracellular glucose concentrations; a similar high degree
of association exists between the intracellular 30Mj concentration
and the extracellular 30MG concentration.

Interestingly, there is

also a high positive correlation between 2,3 DPG and the cpm or intra
cellular 30MG concentration (r = 0.92 for the control group and
r = 0.77 for the experimental group).

Since 2,3 DPG and intracellular

30MG concentrations are each correlated with the same variable (extra
cellular 30MG or glucose concentrations) to a high degree, it is pre
dictable they would be correlated with each other.

Although the

level of intracellular 30MG or glucose does not solely determine
2,3 DPG levels, it is biochemically reasonable they should be corre
lated.

119

CO

c
O
•H
-P
cd
co
C

C5 +>
P-t C
Q 0)

o

•H

cd
p

ao

UD

-p

0)
«

s o5
P, in
O -P

-p co
C
O
O -H

*+^

o G
H 0)
co o

•»

g

cA

p

ao

-P

rn
pq

G
0)

o

CM

CA

rH

CJ1

p
G
CD

G

o

CA O

X3

§

P

OO

o

G

E
P,
o

On
On

co

O

O

On

CO
G
O

<+H
P
CD
O

0)
G
tiD
CD

O

o

•H

cd
rH
CD

G
G
O

p

CD
W
O
O

cd
G
P
G
CD
O

o

1A
PQ

P G

i—I

o
o

o

NO
i—I

o

G
O
CO

O
0
Ph

H O
CO O

G

O
*H
CO
CO

G

co
G
O
•H

0)

•H
O
•H

P

G
G
cd
CD
G
•H
i—I

CD
XI
P

p
O
0
P,
O
rH
CO

n

n

G

PQ

TJ

§
o

Ph

0
i—I

-p

cd
G

§ *

P
O
•H CA cd
P •* G
cd cm p
i—I
G
0
0
G •• O
G G G
OOP
O P O

C
o

•H

P

§

n *h

o

•H

GOp,
CD P O
•H i—I
OOTd
•H
G
P Td cd
CD
O
O O
Ph

C—

C
o

P o E

P

O

r--

CO

G CM
Td o
O Td
CD
CO

On

o

<D
o
G
O
O

<A

OJ

ex

c

co cd O
CD P Ph
P.-P «

CO

rH
I—I

s

co x) C
J15 Sro -h°

§

o

* o
oj o

•H fA •
co
r
CO

CD

o

<A C

cr

co

1A
O
i—I

o

-p

w

PQ

1A
O
r—I

Q

CM
G

On

co

O

o

CA

cd
CM

'ap
G
0
i—I
O
G

P
G
O
O

E
■H

G
0

I-

IIT

..................................... —

—— —

I

SUMARY

120

121

For ten months, two groups of rats (six in each) were fed
commercial rat pellets (control group) or rat pellets plus cholesterol
(1%) and cholic acid (0.25%).

A blood sample from each animal was

divided into three aliquots for three separate experiments on the
erythrocytes: a membrane cholesterol and phospholipid determination, a
30MG transport determination, and a 2,3 DPG determination.

The 30MG

uptake and 2,3 DPG aliquots of blood were incubated in the same five
concentrations of 30MG or glucose respectively.
The experimental group of animals exhibited a 5>0.3% rise in mem
brane cholesterol when compared to the control group (p < 0.01), while
the membrane phospholipid content of the experimental group declined
36.8% when compared to the control animals (p < 0.05). The C/PL ratio
(w/w) increased from O.Idi for the control group to 1.10 for the ex
perimental group (p < 0.01).
The 30MG transport was approximately 30% less in the experimental
animals* erythrocytes, for the physiologic incubation concentrations
of 60 and ?5 mg% (p < 0.25). At the same incubation concentrations,
using glucose, the 2,3 DPG concentrations dropped approximately 10%
in the experimental group as compared to the control animals (p < 0.25).
The transport of 30MG and the levels of 2,3 DPG were optimum at the
blood glucose value of 75 mg%. There was apparently a high degree of
correlation between intracellular 30MG and 2,3 DPG concentrations;
r = 0.92 for the control animals and r = 0.77 for the experimental
group.
A significant rise in the rat erythrocyte membrane cholesterol
content, plus a concomitant decrease in membrane phospholipids were
associated with impaired 30MG transport, Since glucose and 30MG utilize the same membrane carrier (the band 3 protein in human erythro
cytes), the parallel decline in 2,3 DPG concentrations in cholesterolrich erythrocytes may reflect lower intracellular glucose and 1,3 DPG
levels.
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